data_2epx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2epx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.618 0.723 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -34.45 14.64 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -141.07 134.88 30.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -153.3 113.8 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.85 143.14 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -103.9 -27.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -54.61 -40.49 68.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -126.57 -38.16 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.32 12.98 4.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 157.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.13 145.59 51.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.29 175.8 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 50.2 mt -116.61 -25.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -116.31 167.93 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -72.21 -55.75 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -32.58 55.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.0 m -64.67 -27.18 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 tp -81.62 -54.8 5.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.7 mt -52.0 -37.45 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -51.93 -33.96 39.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.01 -34.77 78.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -117.93 35.53 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.57 -46.13 2.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -118.7 -43.09 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.855 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 5.1 mttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -34.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -143.04 132.41 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -151.91 118.02 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.92 143.07 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.2 -27.11 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.83 -37.54 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.41 -39.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.82 13.2 4.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 157.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 143.58 51.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -146.63 171.73 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.1 mt -114.41 -24.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -114.6 170.87 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -78.51 -49.02 14.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -35.68 76.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.1 t -62.15 -26.65 68.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.6 tp -78.67 -54.97 5.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 76.6 mt -51.97 -36.01 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -51.93 -64.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -36.09 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.67 -37.02 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -113.0 33.12 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.27 -65.68 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -96.49 -45.29 6.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.89 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 29.8 mttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.607 0.717 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -32.87 17.77 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.338 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -137.7 127.2 24.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -150.19 118.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.8 t -51.89 142.25 15.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.88 -27.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -57.75 -27.64 63.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.4 p -136.76 -41.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.11 13.48 4.0 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 156.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.44 51.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.88 -178.56 6.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.0 mt -118.93 -31.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -113.68 168.78 9.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -73.41 -54.51 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -31.97 48.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.144 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.1 m -65.46 -34.37 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.67 -53.18 11.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.71 -37.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -51.83 -63.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.96 -32.4 33.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.72 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -113.99 35.26 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.74 -63.36 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.99 -45.12 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.905 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 19.0 mttp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.577 0.703 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -33.1 16.97 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -138.38 128.42 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.5 118.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 31.4 t -51.9 142.55 15.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.25 -27.06 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.05 -25.64 61.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.04 -41.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.07 13.89 3.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.92 156.46 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.89 144.65 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.2 179.48 7.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.45 -30.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.56 171.35 7.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -75.2 -52.65 10.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.6 t -55.59 -29.5 59.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.83 -29.05 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.51 -53.66 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 70.1 mt -51.71 -37.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -52.25 -63.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -52.16 -32.49 36.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.58 -37.92 89.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -114.47 35.57 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.04 -62.44 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -100.87 -43.79 5.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 26.9 mttp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.561 0.696 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -33.01 17.77 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.755 2.303 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -136.79 125.14 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.01 118.21 6.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.8 142.77 14.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.1 -27.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -56.91 -33.84 67.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -131.16 -39.92 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.81 13.13 4.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -51.79 156.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.55 145.54 51.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -147.83 -175.58 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 56.8 mt -121.18 -34.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -108.49 179.83 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -84.0 -55.37 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -31.63 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.4 p -65.64 -41.33 92.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.2 tp -67.07 -54.35 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.72 -38.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -51.83 -62.37 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -52.6 -30.83 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -66.14 -37.16 85.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -115.36 35.91 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.33 -60.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -102.73 -45.36 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.835 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.532 0.682 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -33.13 17.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.383 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -143.12 132.91 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.67 115.58 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.2 t -51.93 143.09 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.8 pt -103.25 -27.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -54.21 -41.39 68.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.84 -37.9 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.45 13.09 4.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -51.69 157.25 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 141.25 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.83 169.21 18.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 55.8 mt -111.19 -24.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -116.26 176.19 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.42 -56.27 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.71 -34.23 51.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 48.2 m -63.74 -31.69 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.76 -54.35 7.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 62.7 mt -51.68 -37.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -52.01 -64.27 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -51.51 -39.33 57.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -57.79 -33.91 69.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -117.94 35.22 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.73 -56.04 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.28 -22.67 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.595 0.712 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.71 17.99 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -130.43 126.83 37.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -151.81 117.71 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 38.2 t -51.93 143.85 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.72 -27.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.07 -31.86 65.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -133.49 -40.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.37 13.22 3.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -51.76 157.68 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.46 143.64 50.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -146.47 175.53 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.7 -24.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 170.81 8.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -79.28 -43.0 24.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.5 p -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 2.8 t -71.28 -27.1 63.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.12 -55.31 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 68.9 mt -51.55 -37.54 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -51.92 -63.51 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.87 -34.15 39.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.65 -37.48 87.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -112.02 34.37 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.87 -66.37 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -95.69 -48.45 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.538 0.685 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.82 17.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -144.03 131.25 20.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.5 116.76 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.7 t -51.91 143.63 13.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.9 pt -104.03 -27.58 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -54.77 -38.99 67.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -127.92 -38.58 1.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.61 13.16 4.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -51.85 157.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.05 51.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -147.77 173.22 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.72 -24.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.04 176.17 5.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.99 -54.13 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.93 -25.63 44.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.7 m -72.67 -26.71 61.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.5 tp -80.72 -54.1 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.3 mt -51.72 -38.12 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -51.72 -63.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -51.77 -37.19 50.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.13 -36.26 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -116.12 36.96 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.38 -62.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -97.96 -25.98 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.542 0.687 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.67 18.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -137.04 126.2 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -145.09 116.46 8.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.4 t -51.92 143.06 14.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.6 pt -103.23 -27.33 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.71 -38.6 67.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.6 p -128.36 -38.54 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.86 13.23 4.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -51.91 157.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.79 144.62 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.31 176.26 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.25 -24.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -118.56 174.28 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.43 -53.58 6.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.89 -26.23 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.9 m -72.5 -26.96 61.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 tp -81.21 -53.24 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.957 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.4 mt -51.75 -38.52 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -51.75 -63.35 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -51.83 -37.02 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.09 -34.63 73.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 -117.62 36.52 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -127.22 -57.37 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.41 -25.26 12.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.875 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 23.0 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -32.65 18.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.36 129.26 18.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.22 117.22 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 20.9 t -52.26 142.52 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -102.91 -27.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -53.89 -39.94 66.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.9 p -127.14 -38.15 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.53 13.37 4.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -52.28 157.04 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.04 142.83 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.99 170.58 16.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.84 -24.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -114.29 174.75 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.57 -38.25 18.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 6.9 p -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.8 t -74.43 -26.84 60.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 tp -77.25 -55.73 5.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.8 mt -51.62 -38.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.198 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -52.15 -63.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -51.7 -36.4 46.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.29 -35.18 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -117.34 35.22 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -126.57 -58.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.89 -25.64 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 25.6 mttp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.606 0.717 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -33.03 17.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -137.05 127.69 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -149.98 118.72 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.87 143.12 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.3 -27.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -56.59 -32.72 65.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -132.32 -40.13 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.98 13.26 4.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -51.89 156.68 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.14 143.83 51.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -146.46 -177.83 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.79 -32.46 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -111.69 173.85 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -77.17 -54.74 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.8 t -54.25 -30.12 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.4 m -67.51 -29.91 69.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.9 tp -79.34 -53.54 6.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.98 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.3 mt -51.73 -38.02 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -51.87 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -51.87 -31.88 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.835 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.66 -36.96 85.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -115.04 36.39 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.18 -62.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.54 -45.51 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.851 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 35.8 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.571 0.701 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -33.04 17.19 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -138.26 128.44 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.19 118.29 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.9 t -51.88 140.52 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 6.9 pt -101.47 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.91 -30.22 63.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.41 -40.48 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.96 14.17 3.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.448 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.62 156.14 2.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.37 144.05 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.0 -179.21 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.47 -30.85 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -113.66 173.95 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -77.42 -55.37 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.4 t -53.22 -29.94 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.176 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.4 m -67.73 -32.6 73.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 tp -76.01 -53.7 7.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.1 mt -52.42 -37.25 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -51.96 -64.22 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -51.94 -30.63 25.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -67.8 -36.68 80.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -115.9 38.74 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.99 -51.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.73 -47.15 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.565 0.698 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.73 17.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.91 127.14 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -150.2 119.15 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 37.5 t -51.95 142.74 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.11 -27.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -57.35 -28.27 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.71 -40.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.36 13.43 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 156.01 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.65 143.32 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -145.23 -175.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 65.3 mt -119.68 -35.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -109.77 -179.59 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.87 -54.81 4.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.8 p -51.82 -30.69 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.4 p -67.09 -39.46 86.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 17.0 tp -69.18 -45.95 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.97 -38.45 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -61.89 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -53.35 -30.41 39.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -67.42 -35.95 80.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -115.11 33.73 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.94 -61.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -100.95 -45.11 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.6 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.86 17.73 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.332 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -137.61 125.45 22.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -147.58 119.28 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 47.5 t -51.89 145.04 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -104.44 -27.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.18 -34.57 66.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.0 p -131.47 -39.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.95 13.98 3.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 156.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.2 144.81 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.072 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.15 -178.06 6.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.44 -31.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.35 -177.38 3.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.73 -52.72 5.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -25.91 59.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -72.81 -28.23 62.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.38 -51.71 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.7 mt -51.66 -38.11 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -51.89 -61.14 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -54.77 -26.81 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.25 -31.19 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -118.41 31.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -119.34 -52.62 2.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.48 -48.38 2.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.554 0.692 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -33.0 17.39 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.31 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.75 129.06 27.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -151.65 118.12 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 34.1 t -51.93 142.65 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.25 -27.22 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.03 -24.53 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -140.15 -41.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.01 3.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 156.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.334 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.21 142.33 51.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.126 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -145.15 -179.12 6.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.42 -34.58 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -109.41 175.96 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.43 -51.32 9.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -33.46 65.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -32.89 74.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.69 -54.22 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 78.4 mt -51.7 -37.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -52.09 -63.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -51.97 -32.68 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -65.14 -36.08 83.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -116.03 35.58 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.98 -47.4 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -117.72 -46.81 2.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 28.9 mttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.571 0.7 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.67 18.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.375 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.14 128.36 24.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.97 118.81 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.8 t -52.07 141.29 18.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.96 -26.98 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -56.8 -32.1 65.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.4 p -132.69 -40.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.78 14.07 3.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 156.31 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.727 0.298 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.34 144.72 51.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -147.12 179.67 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.87 -31.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -113.2 175.43 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.56 -53.73 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.4 t -54.51 -29.31 50.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.9 -29.95 68.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.8 tp -79.21 -54.61 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.57 -37.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -52.03 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -52.54 -29.38 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -70.22 -35.49 73.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -115.86 39.85 2.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -127.54 -54.09 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -112.98 -47.14 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.929 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.579 0.704 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -32.65 18.27 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -139.03 127.28 22.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.972 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -148.2 116.93 6.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 17.4 t -52.11 139.94 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.72 -27.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.0 -37.99 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.2 p -128.51 -38.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.03 13.21 4.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -52.87 157.12 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.97 143.79 50.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -146.42 -178.76 6.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.4 mt -119.21 -31.24 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -112.97 161.55 16.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -67.12 -55.32 14.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.7 t -53.45 -30.85 42.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 47.1 m -67.05 -30.98 71.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -76.83 -53.68 7.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.47 -37.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -51.56 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -51.78 -35.28 43.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -61.32 -35.62 77.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -115.76 32.48 6.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.22 -65.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -95.12 -25.56 16.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 179.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.0 mptt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.605 0.716 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.89 124.25 21.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.23 118.42 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.5 t -52.03 142.87 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -103.37 -27.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -57.56 -28.01 63.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -136.59 -40.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.89 13.84 3.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 156.19 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.1 146.15 50.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -148.1 -177.3 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.78 -33.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -112.85 175.96 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -78.61 -53.5 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.6 t -54.91 -26.59 37.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -71.89 -30.01 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.48 -53.97 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.65 -37.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -51.8 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -52.93 -29.44 28.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -68.99 -36.34 77.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -113.45 32.86 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.33 -64.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -96.05 -50.55 4.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.849 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 14.8 mttm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.557 0.694 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.84 17.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -143.9 130.99 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -151.63 115.38 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 19.5 t -51.88 140.19 20.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.26 -27.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -54.66 -34.82 62.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.71 -39.66 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.69 12.94 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.51 156.07 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.54 140.75 52.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -143.17 173.98 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.26 -25.09 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.09 170.81 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -76.35 -54.7 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.3 p -55.9 -25.37 42.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.7 t -72.37 -28.2 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.8 tp -80.05 -54.82 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.61 -35.14 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -53.92 -64.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -52.13 -34.96 46.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.36 -33.38 74.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -118.71 32.38 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.88 -47.4 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -116.6 -26.18 7.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 10.1 mttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.522 0.677 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.07 17.42 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.39 130.91 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.892 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -151.69 117.68 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.56 142.85 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.54 -27.35 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -57.84 -23.62 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -141.26 -41.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.45 3.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.505 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.47 156.44 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.47 142.07 51.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -144.79 172.6 12.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.19 -25.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -116.84 173.94 6.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -77.31 -54.6 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.1 t -53.5 -30.54 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 9.3 m -67.08 -31.08 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 tp -77.87 -57.64 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -51.5 -35.96 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -53.3 -63.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -33.21 34.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -63.66 -36.63 84.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -116.37 34.95 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.99 -44.51 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -119.66 -46.68 2.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 23.3 p -174.4 145.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 110.811 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.5 m -165.09 144.24 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 176.96 -157.23 22.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 5.5 m -147.17 120.08 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 41.1 t -92.37 112.61 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.11 28.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 12.1 t -171.7 142.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -69.32 137.49 29.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.75 160.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -139.67 160.69 60.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.618 0.723 . . . . 0.0 110.823 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -34.45 14.64 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -141.07 134.88 30.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -153.3 113.8 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.85 143.14 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -103.9 -27.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -54.61 -40.49 68.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -126.57 -38.16 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.32 12.98 4.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 157.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.13 145.59 51.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.29 175.8 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 50.2 mt -116.61 -25.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -116.31 167.93 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -72.21 -55.75 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -32.58 55.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.0 m -64.67 -27.18 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 tp -81.62 -54.8 5.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.7 mt -52.0 -37.45 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -51.93 -33.96 39.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.01 -34.77 78.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -117.93 35.53 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.57 -46.13 2.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -118.7 -43.09 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -61.46 -72.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.3 p -96.07 25.6 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -103.63 -131.14 7.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -79.59 147.69 31.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 52.55 73.31 0.97 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.555 0.693 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.273 . . . . 0.0 112.288 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 39.6 t -108.77 98.91 8.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -163.49 -73.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 140.8 43.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 8.5 p -119.79 28.63 8.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 34.0 p -53.92 163.83 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.883 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 CA-C-O 119.125 -0.82 . . . . 0.0 112.515 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 30.4 p -121.47 163.03 19.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 m -136.02 138.57 42.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -70.74 132.69 22.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 30.5 t -96.71 -35.86 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.814 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 43.0 t -127.3 96.75 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -138.86 97.2 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 6.3 t -125.75 125.2 42.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.8 0.333 . . . . 0.0 111.133 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 131.44 173.98 13.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -107.11 136.09 47.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -128.62 160.61 61.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -34.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -143.04 132.41 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -151.91 118.02 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.92 143.07 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.2 -27.11 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.83 -37.54 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.41 -39.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.82 13.2 4.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 157.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 143.58 51.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -146.63 171.73 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.1 mt -114.41 -24.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -114.6 170.87 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -78.51 -49.02 14.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -35.68 76.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.1 t -62.15 -26.65 68.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.6 tp -78.67 -54.97 5.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 76.6 mt -51.97 -36.01 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -51.93 -64.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -36.09 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.67 -37.02 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -113.0 33.12 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.27 -65.68 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -96.49 -45.29 6.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -60.11 -70.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 15.1 t -129.38 172.3 11.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -167.21 176.16 42.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.491 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -114.91 34.87 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -147.28 73.43 11.91 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -27.15 26.58 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.278 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 1.8 p -76.64 81.42 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -175.19 170.27 43.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -16.87 37.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 77.1 p -84.88 123.21 30.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.4 m -85.65 -31.15 22.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.467 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 60.8 p -161.19 117.8 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 38.9 m -114.43 173.83 6.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 144.38 110.3 0.7 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 10.5 t -167.53 154.73 8.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 37.5 m -145.05 169.4 18.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -153.53 91.7 0.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 9.9 t -88.68 -28.97 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.13 150.97 28.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -122.32 154.05 38.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -113.16 160.65 30.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.717 . . . . 0.0 110.857 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -32.87 17.77 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.338 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -137.7 127.2 24.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -150.19 118.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.8 t -51.89 142.25 15.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.88 -27.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -57.75 -27.64 63.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.4 p -136.76 -41.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.11 13.48 4.0 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 156.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.44 51.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.88 -178.56 6.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.0 mt -118.93 -31.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -113.68 168.78 9.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -73.41 -54.51 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -31.97 48.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.144 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.1 m -65.46 -34.37 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.67 -53.18 11.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.71 -37.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -51.83 -63.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.96 -32.4 33.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.72 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -113.99 35.26 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.74 -63.36 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.99 -45.12 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -57.65 -67.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.905 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.2 p -106.28 160.49 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 131.83 -179.16 17.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.55 39.42 2.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 110.896 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 160.32 69.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 80.42 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.721 2.281 . . . . 0.0 112.311 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 27.2 p -53.13 -58.33 7.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 171.41 -73.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 176.8 6.27 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.712 2.275 . . . . 0.0 112.38 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 58.4 m -62.38 144.59 55.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.835 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 23.0 m -136.54 126.9 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.485 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 34.9 p -60.76 140.65 57.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.1 t -133.2 -51.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 172.37 -30.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 53.0 m -65.69 113.51 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.884 0.373 . . . . 0.0 110.82 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 66.4 p -105.5 172.64 6.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.81 92.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.1 p -65.33 174.44 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.352 . . . . 0.0 111.115 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 74.81 135.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -158.55 126.94 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -130.05 160.7 64.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.577 0.703 . . . . 0.0 110.867 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -33.1 16.97 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -138.38 128.42 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.5 118.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 31.4 t -51.9 142.55 15.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.25 -27.06 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.05 -25.64 61.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.04 -41.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.07 13.89 3.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.92 156.46 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.89 144.65 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.2 179.48 7.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.45 -30.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.56 171.35 7.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -75.2 -52.65 10.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.6 t -55.59 -29.5 59.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.83 -29.05 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.51 -53.66 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 70.1 mt -51.71 -37.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -52.25 -63.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -52.16 -32.49 36.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.58 -37.92 89.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -114.47 35.57 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.04 -62.44 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -100.87 -43.79 5.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.41 -66.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.3 p -108.83 139.7 43.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 164.87 -117.01 0.73 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -87.8 81.99 7.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp 63.05 160.64 0.12 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -16.41 37.29 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.367 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 1.5 t 52.91 55.61 8.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 165.09 67.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 130.82 19.9 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.682 2.254 . . . . 0.0 112.339 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 32.8 t -157.14 164.9 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 11.6 t -124.42 42.58 3.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.82 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.49 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 31.1 t -165.08 128.17 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 36.6 p -94.72 -176.53 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.39 147.45 18.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 14.9 m -139.61 154.13 47.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.825 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 3.0 p -140.05 137.88 34.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.853 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.77 -142.83 4.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 23.6 p -111.66 123.36 50.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.166 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.93 99.41 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -103.1 56.88 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -117.26 160.62 36.8 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.561 0.696 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -33.01 17.77 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.755 2.303 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -136.79 125.14 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.01 118.21 6.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.8 142.77 14.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.1 -27.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -56.91 -33.84 67.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -131.16 -39.92 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.81 13.13 4.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -51.79 156.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.55 145.54 51.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -147.83 -175.58 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 56.8 mt -121.18 -34.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -108.49 179.83 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -84.0 -55.37 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -31.63 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.4 p -65.64 -41.33 92.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.2 tp -67.07 -54.35 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.72 -38.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -51.83 -62.37 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -52.6 -30.83 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -66.14 -37.16 85.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -115.36 35.91 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.33 -60.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -102.73 -45.36 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.46 -68.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.8 p -103.83 38.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -133.91 -60.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.07 128.03 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -101.56 160.7 25.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.544 0.687 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.42 0.9 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 20.3 m -115.39 -30.22 6.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -92.14 -175.83 42.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 130.94 20.29 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.389 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 5.4 t -132.64 116.22 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 48.1 t -115.33 124.83 52.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.508 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 58.1 m -91.17 -60.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.811 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 1.4 t -87.68 128.57 35.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -86.4 -168.07 44.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 40.7 t -165.16 148.45 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.849 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 46.0 p -106.07 120.09 40.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.55 124.81 3.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 43.0 p -115.66 123.68 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.71 151.09 26.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.23 156.4 31.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -128.1 160.57 61.01 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.532 0.682 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -33.13 17.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.383 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -143.12 132.91 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.67 115.58 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.2 t -51.93 143.09 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.8 pt -103.25 -27.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -54.21 -41.39 68.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.84 -37.9 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.45 13.09 4.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -51.69 157.25 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 141.25 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.83 169.21 18.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 55.8 mt -111.19 -24.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -116.26 176.19 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.42 -56.27 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.71 -34.23 51.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 48.2 m -63.74 -31.69 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.1 tp -74.76 -54.35 7.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 62.7 mt -51.68 -37.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -52.01 -64.27 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -51.51 -39.33 57.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -57.79 -33.91 69.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -117.94 35.22 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.73 -56.04 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.28 -22.67 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -90.14 -62.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 10.2 p -120.06 -172.45 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.107 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 95.4 -120.39 6.5 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.451 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -58.23 98.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -130.37 72.39 81.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.625 0.726 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.73 4.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 26.2 p -107.45 96.41 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -66.63 -72.2 0.8 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 103.42 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 1.7 t -70.58 108.23 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.9 t -83.8 93.5 7.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.496 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 16.2 t -169.1 132.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.367 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.3 t -159.78 160.93 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.44 39.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 3.7 m -123.01 167.58 13.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 95.7 p -59.92 114.97 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 158.74 -67.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 4.0 t -62.04 155.16 24.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -153.71 -98.33 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.49 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -168.88 166.5 11.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.03 160.68 26.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.863 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.71 17.99 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -130.43 126.83 37.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -151.81 117.71 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 38.2 t -51.93 143.85 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.72 -27.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.07 -31.86 65.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -133.49 -40.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.37 13.22 3.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -51.76 157.68 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.46 143.64 50.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -146.47 175.53 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.7 -24.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 170.81 8.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -79.28 -43.0 24.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.5 p -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 2.8 t -71.28 -27.1 63.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.12 -55.31 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 68.9 mt -51.55 -37.54 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -51.92 -63.51 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.87 -34.15 39.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.65 -37.48 87.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -112.02 34.37 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.87 -66.37 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -95.69 -48.45 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -56.54 -72.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.2 t -126.3 164.1 21.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.177 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.66 31.37 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.463 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -114.21 35.57 4.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -127.92 160.66 60.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.557 0.694 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 89.52 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.318 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 9.3 p -107.79 -43.94 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 138.14 -167.22 25.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 126.51 13.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.358 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 36.3 p -124.74 71.74 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 4.2 m -100.5 145.53 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.848 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.501 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.1 m -140.91 133.61 28.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.898 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 52.7 p -114.67 131.53 56.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 178.78 116.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 4.6 m -131.2 130.84 43.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.823 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 97.0 p -84.84 174.93 9.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.815 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 101.18 67.33 0.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 13.1 m -116.88 74.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.131 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -170.83 115.34 0.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -81.14 129.21 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -129.84 159.1 71.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.82 17.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -144.03 131.25 20.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.5 116.76 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.7 t -51.91 143.63 13.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.9 pt -104.03 -27.58 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -54.77 -38.99 67.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -127.92 -38.58 1.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.61 13.16 4.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -51.85 157.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.05 51.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -147.77 173.22 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.72 -24.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.04 176.17 5.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.99 -54.13 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.93 -25.63 44.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.7 m -72.67 -26.71 61.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.5 tp -80.72 -54.1 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.3 mt -51.72 -38.12 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -51.72 -63.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -51.77 -37.19 50.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.13 -36.26 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -116.12 36.96 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.38 -62.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -97.96 -25.98 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -83.65 -64.95 1.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 12.2 p -116.2 123.19 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 164.45 -146.87 11.85 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.63 133.15 35.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.21 73.69 0.83 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.562 0.696 . . . . 0.0 110.86 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 124.99 11.64 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.644 2.23 . . . . 0.0 112.372 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 37.4 t -127.86 150.38 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 174.93 167.15 33.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 93.96 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.353 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 12.7 t -69.47 -37.92 77.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.18 126.52 35.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.519 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 45.3 t -124.99 105.56 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 42.1 m -71.41 122.7 20.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -176.44 -101.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 5.1 t -109.88 29.73 7.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.874 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 85.4 p -139.75 -178.49 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 156.04 -84.25 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 8.9 t -137.52 142.63 41.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.135 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -68.79 -115.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.73 31.08 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -131.78 160.75 66.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.542 0.687 . . . . 0.0 110.922 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.67 18.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -137.04 126.2 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -145.09 116.46 8.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.4 t -51.92 143.06 14.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.6 pt -103.23 -27.33 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.71 -38.6 67.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.6 p -128.36 -38.54 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.86 13.23 4.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -51.91 157.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.79 144.62 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.31 176.26 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.25 -24.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -118.56 174.28 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.43 -53.58 6.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.89 -26.23 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.9 m -72.5 -26.96 61.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 tp -81.21 -53.24 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.957 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.4 mt -51.75 -38.52 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -51.75 -63.35 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -51.83 -37.02 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.09 -34.63 73.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 -117.62 36.52 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -127.22 -57.37 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.41 -25.26 12.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -84.04 -63.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 11.9 p -116.35 -172.63 2.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 107.08 101.2 2.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 54.53 36.61 26.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -114.45 160.06 34.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.575 0.702 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 163.6 37.68 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.371 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 46.9 m -157.54 127.85 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 174.87 69.05 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 168.77 20.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.636 2.224 . . . . 0.0 112.318 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 21.7 t -104.48 151.3 23.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 59.6 p -171.43 156.38 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.476 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.5 t -159.37 145.25 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 48.9 p -166.95 124.51 1.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.838 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 173.03 119.97 0.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 1.8 p -105.54 137.96 42.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 4.2 p -92.88 53.76 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 143.07 149.13 5.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.455 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 40.0 p -146.39 115.53 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.348 . . . . 0.0 111.129 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -108.23 -159.1 19.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.2 -178.0 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -156.34 160.65 30.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -32.65 18.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.36 129.26 18.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.22 117.22 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 20.9 t -52.26 142.52 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -102.91 -27.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -53.89 -39.94 66.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.9 p -127.14 -38.15 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.53 13.37 4.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -52.28 157.04 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.04 142.83 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.99 170.58 16.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.84 -24.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -114.29 174.75 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.57 -38.25 18.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 6.9 p -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.8 t -74.43 -26.84 60.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 tp -77.25 -55.73 5.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.8 mt -51.62 -38.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.198 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -52.15 -63.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -51.7 -36.4 46.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.29 -35.18 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -117.34 35.22 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -126.57 -58.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.89 -25.64 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -84.27 -69.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 11.9 p -109.37 37.31 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -125.93 20.93 6.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -163.09 128.52 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -52.37 160.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 120.24 7.05 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 4.4 m -108.1 156.32 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -55.75 -73.47 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 129.16 17.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 0.0 112.376 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 2.2 m -169.65 168.82 8.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 3.4 m -81.52 -55.38 4.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.448 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 79.7 p -171.4 129.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 50.3 m -111.37 170.35 8.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.05 41.74 2.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.0 m -74.05 118.54 17.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 3.3 p -138.94 152.6 47.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.12 146.42 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.7 m -89.43 122.94 33.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.115 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 105.26 167.23 23.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 175.09 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -144.01 160.68 48.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.606 0.717 . . . . 0.0 110.862 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -33.03 17.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -137.05 127.69 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -149.98 118.72 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.87 143.12 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.3 -27.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -56.59 -32.72 65.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -132.32 -40.13 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.98 13.26 4.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -51.89 156.68 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.14 143.83 51.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -146.46 -177.83 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.79 -32.46 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -111.69 173.85 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -77.17 -54.74 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.8 t -54.25 -30.12 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.4 m -67.51 -29.91 69.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.9 tp -79.34 -53.54 6.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.98 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.3 mt -51.73 -38.02 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -51.87 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -51.87 -31.88 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.835 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.66 -36.96 85.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -115.04 36.39 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.18 -62.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.54 -45.51 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -57.52 -65.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.2 p -109.5 161.94 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 130.09 -103.36 0.57 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.484 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -120.45 142.97 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm 51.84 68.15 3.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.567 0.699 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 97.67 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.715 2.276 . . . . 0.0 112.328 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.84 165.06 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 167.82 73.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -19.71 36.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.255 . . . . 0.0 112.391 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 36.0 p -80.44 174.92 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 63.0 p -130.67 102.77 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.15 -0.805 . . . . 0.0 112.485 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 97.9 p -137.09 161.59 35.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 8.2 t -126.55 131.87 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.12 160.62 28.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 15.3 t -165.8 132.19 2.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 2.8 p -151.75 165.29 34.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 155.06 97.27 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.3 p -126.58 122.53 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.12 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -172.37 139.76 5.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.523 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -89.04 90.07 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -102.11 160.66 25.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.701 . . . . 0.0 110.914 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -33.04 17.19 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -138.26 128.44 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.19 118.29 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.9 t -51.88 140.52 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 6.9 pt -101.47 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.91 -30.22 63.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.41 -40.48 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.96 14.17 3.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.448 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.62 156.14 2.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.37 144.05 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.0 -179.21 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.47 -30.85 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -113.66 173.95 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -77.42 -55.37 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.4 t -53.22 -29.94 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.176 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.4 m -67.73 -32.6 73.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 tp -76.01 -53.7 7.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.1 mt -52.42 -37.25 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -51.96 -64.22 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -51.94 -30.63 25.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -67.8 -36.68 80.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -115.9 38.74 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.99 -51.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.73 -47.15 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -51.62 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 36.7 p -60.01 177.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 53.76 -149.06 15.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -71.68 139.13 49.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -69.36 160.55 78.63 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.591 0.71 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -20.36 35.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.633 2.222 . . . . 0.0 112.4 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 8.4 t -168.52 177.77 5.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.28 19.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 90.12 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.682 2.255 . . . . 0.0 112.333 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 42.8 m -105.27 134.55 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 84.1 p -60.38 -28.68 68.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.484 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.6 t 52.11 33.9 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 35.9 m -121.22 167.52 12.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 56.6 79.0 0.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 79.6 p -142.95 143.24 31.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 5.6 m -134.57 167.05 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -155.19 -75.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 8.8 t -114.38 142.29 46.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.149 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.99 -131.07 5.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -37.56 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.57 160.71 17.38 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.565 0.698 . . . . 0.0 110.908 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.73 17.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.91 127.14 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -150.2 119.15 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 37.5 t -51.95 142.74 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.11 -27.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -57.35 -28.27 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.71 -40.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.36 13.43 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 156.01 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.65 143.32 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -145.23 -175.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 65.3 mt -119.68 -35.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -109.77 -179.59 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.87 -54.81 4.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.8 p -51.82 -30.69 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.4 p -67.09 -39.46 86.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 17.0 tp -69.18 -45.95 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.97 -38.45 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -61.89 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -53.35 -30.41 39.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -67.42 -35.95 80.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -115.11 33.73 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.94 -61.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -100.95 -45.11 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -59.29 -74.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 14.7 t -126.4 172.42 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 176.33 -73.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -136.05 132.99 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.937 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp 51.88 68.16 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.588 0.709 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -30.14 22.73 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.321 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 3.0 p -59.46 167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -151.71 176.79 29.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -27.69 26.22 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 50.6 m -85.9 162.96 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 22.9 t -132.55 34.12 3.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.508 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 39.3 m -119.13 159.07 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.351 . . . . 0.0 110.889 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.6 t -119.29 149.08 42.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 139.09 122.88 2.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.4 m -126.76 85.74 2.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 1.3 t -111.73 155.23 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 148.74 -103.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.453 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 17.4 p -52.18 122.9 9.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.34 . . . . 0.0 111.162 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.58 -179.48 40.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.71 175.46 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -137.69 160.7 63.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.86 17.73 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.332 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -137.61 125.45 22.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -147.58 119.28 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 47.5 t -51.89 145.04 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -104.44 -27.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.18 -34.57 66.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.0 p -131.47 -39.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.95 13.98 3.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 156.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.2 144.81 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.072 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.15 -178.06 6.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.44 -31.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.35 -177.38 3.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.73 -52.72 5.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -25.91 59.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -72.81 -28.23 62.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.38 -51.71 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.7 mt -51.66 -38.11 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -51.89 -61.14 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -54.77 -26.81 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.25 -31.19 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -118.41 31.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -119.34 -52.62 2.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.48 -48.38 2.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -53.94 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 13.4 p -108.87 24.22 13.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -105.29 178.27 23.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.76 157.73 37.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -147.8 160.68 37.55 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -37.53 9.05 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.318 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 12.7 p -77.81 145.93 36.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -129.4 178.68 17.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 107.7 1.92 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.676 2.251 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 30.8 p -131.58 161.44 32.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.8 p -52.36 -48.65 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.493 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.6 p -69.39 167.51 16.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.344 . . . . 0.0 110.886 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.9 t -170.38 169.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -155.63 -173.82 24.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.6 m -126.86 56.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 1.1 p -105.41 81.76 1.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -71.74 111.48 3.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 9.7 t -78.3 155.58 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 138.67 101.32 0.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.489 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -100.94 114.48 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -120.24 159.3 48.1 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -33.0 17.39 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.31 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.75 129.06 27.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -151.65 118.12 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 34.1 t -51.93 142.65 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.25 -27.22 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.03 -24.53 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -140.15 -41.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.01 3.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 156.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.334 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.21 142.33 51.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.126 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -145.15 -179.12 6.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.42 -34.58 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -109.41 175.96 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.43 -51.32 9.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -33.46 65.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -32.89 74.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.69 -54.22 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 78.4 mt -51.7 -37.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -52.09 -63.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -51.97 -32.68 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -65.14 -36.08 83.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -116.03 35.58 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.98 -47.4 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -117.72 -46.81 2.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -57.2 -73.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.6 p -94.4 -33.6 13.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.85 5.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -84.83 163.13 19.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -101.7 159.29 29.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.92 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.697 2.264 . . . . 0.0 112.383 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 2.8 m -129.27 29.11 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -173.59 179.89 44.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 137.12 34.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.656 2.238 . . . . 0.0 112.31 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 7.5 t -125.62 43.46 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 13.7 m -128.9 62.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.836 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.458 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 19.4 t -123.47 70.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.4 t -92.94 163.7 13.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -133.77 76.66 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 4.3 t -153.52 137.77 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 9.2 m -116.97 122.5 44.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -84.84 -167.8 43.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 5.2 t -172.75 139.35 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 156.65 151.7 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -86.37 93.83 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.887 0.375 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -107.6 160.74 25.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.571 0.7 . . . . 0.0 110.939 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.67 18.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.375 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.14 128.36 24.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.97 118.81 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.8 t -52.07 141.29 18.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.96 -26.98 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -56.8 -32.1 65.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.4 p -132.69 -40.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.78 14.07 3.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 156.31 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.727 0.298 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.34 144.72 51.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -147.12 179.67 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.87 -31.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -113.2 175.43 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.56 -53.73 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.4 t -54.51 -29.31 50.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.9 -29.95 68.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.8 tp -79.21 -54.61 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.57 -37.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -52.03 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -52.54 -29.38 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -70.22 -35.49 73.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -115.86 39.85 2.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -127.54 -54.09 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -112.98 -47.14 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -51.7 -50.09 61.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.5 p -108.58 122.38 46.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 109.52 74.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -83.64 131.04 34.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.393 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -120.48 160.68 42.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.842 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 96.09 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 37.9 t -168.62 144.24 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 144.86 73.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -172.2 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.729 2.286 . . . . 0.0 112.339 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 5.8 p -153.74 148.98 26.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 6.9 p -89.45 130.38 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.145 -0.809 . . . . 0.0 112.514 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 46.0 m -128.25 113.45 15.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.904 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 26.0 p -147.0 112.38 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.821 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -164.89 134.61 3.39 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 6.2 t -171.18 133.18 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.883 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 5.0 m -159.55 169.23 24.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 155.05 133.01 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 34.2 p -119.25 78.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.175 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -138.67 131.78 5.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.52 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 157.6 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -133.48 160.71 67.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.579 0.704 . . . . 0.0 110.875 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -32.65 18.27 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -139.03 127.28 22.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.972 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -148.2 116.93 6.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 17.4 t -52.11 139.94 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.72 -27.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.0 -37.99 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.2 p -128.51 -38.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.03 13.21 4.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -52.87 157.12 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.97 143.79 50.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -146.42 -178.76 6.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.4 mt -119.21 -31.24 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -112.97 161.55 16.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -67.12 -55.32 14.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.7 t -53.45 -30.85 42.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 47.1 m -67.05 -30.98 71.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -76.83 -53.68 7.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.47 -37.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -51.56 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -51.78 -35.28 43.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -61.32 -35.62 77.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -115.76 32.48 6.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.22 -65.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -95.12 -25.56 16.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -84.85 -71.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.3 p -109.88 122.3 47.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 131.94 -114.5 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -68.87 109.51 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.9 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -59.9 160.69 14.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.534 0.683 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 111.0 2.69 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 47.8 t -58.55 -48.89 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -74.4 -170.34 23.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.94 15.44 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.719 2.28 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 3.9 t -81.85 161.5 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 6.4 m -122.5 -176.53 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.481 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 12.1 t -113.99 -36.44 4.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 110.825 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.7 m -85.29 151.69 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -149.81 -91.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 113.21 25.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.347 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 2.7 t -101.26 136.72 40.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 146.18 146.54 4.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 6.1 p -91.82 127.75 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 -145.53 18.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 150.01 26.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.922 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -91.73 160.7 35.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.716 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.89 124.25 21.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.23 118.42 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.5 t -52.03 142.87 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -103.37 -27.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -57.56 -28.01 63.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -136.59 -40.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.89 13.84 3.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 156.19 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.1 146.15 50.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -148.1 -177.3 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.78 -33.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -112.85 175.96 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -78.61 -53.5 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.6 t -54.91 -26.59 37.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -71.89 -30.01 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.48 -53.97 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.65 -37.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -51.8 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -52.93 -29.44 28.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -68.99 -36.34 77.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -113.45 32.86 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.33 -64.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -96.05 -50.55 4.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -55.13 -74.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.6 t -124.46 164.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 127.45 -69.33 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -105.77 77.33 1.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.868 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 160.69 0.12 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.543 0.687 . . . . 0.0 110.949 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 128.65 16.33 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.373 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.48 132.41 9.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -173.6 172.08 44.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 122.65 9.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 25.5 p -164.62 120.21 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.3 t -167.86 -176.52 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 34.4 p -132.5 74.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.1 t -128.27 85.04 2.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 164.45 156.94 9.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.443 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 11.1 p -166.3 129.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 30.0 m -76.31 152.56 36.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -111.58 -160.02 15.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.462 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 2.1 t -174.28 121.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 178.98 174.99 45.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.481 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -98.83 124.43 43.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -132.16 160.74 66.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.557 0.694 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.84 17.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -143.9 130.99 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -151.63 115.38 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 19.5 t -51.88 140.19 20.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.26 -27.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -54.66 -34.82 62.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.71 -39.66 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.69 12.94 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.51 156.07 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.54 140.75 52.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -143.17 173.98 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.26 -25.09 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.09 170.81 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -76.35 -54.7 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.3 p -55.9 -25.37 42.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.7 t -72.37 -28.2 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.8 tp -80.05 -54.82 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.61 -35.14 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -53.92 -64.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -52.13 -34.96 46.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.36 -33.38 74.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -118.71 32.38 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.88 -47.4 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -116.6 -26.18 7.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -84.74 -69.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.7 p -107.16 33.32 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -127.35 -70.84 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.55 169.75 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.76 160.7 76.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 127.62 14.85 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 0.0 112.368 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 38.9 m -123.83 60.37 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.56 70.85 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 79.54 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 3.8 m -123.74 101.65 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 10.0 t -63.28 -35.68 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.16 -0.8 . . . . 0.0 112.434 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 14.1 m -78.1 96.09 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.92 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 54.7 p -114.82 176.41 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.31 -61.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.483 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 6.2 p -144.42 166.36 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 29.6 t -97.97 -42.17 7.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 173.65 -155.91 23.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 90.4 m -93.76 107.95 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.176 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.1 174.16 42.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -108.66 109.25 20.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -67.81 160.67 72.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.522 0.677 . . . . 0.0 110.897 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.07 17.42 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.39 130.91 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.892 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -151.69 117.68 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.56 142.85 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.54 -27.35 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -57.84 -23.62 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -141.26 -41.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.45 3.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.505 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.47 156.44 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.47 142.07 51.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -144.79 172.6 12.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.19 -25.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -116.84 173.94 6.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -77.31 -54.6 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.1 t -53.5 -30.54 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 9.3 m -67.08 -31.08 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 tp -77.87 -57.64 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -51.5 -35.96 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -53.3 -63.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -33.21 34.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -63.66 -36.63 84.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -116.37 34.95 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.99 -44.51 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -119.66 -46.68 2.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -58.38 -70.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.9 p -97.92 135.6 39.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 126.85 -93.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.463 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -101.58 138.45 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt 51.85 68.25 3.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 165.09 32.14 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 4.0 t -150.35 159.97 44.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -144.64 72.34 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -35.72 12.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 1.5 m 57.95 41.19 24.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 4.7 m -124.87 95.77 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.486 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.618 0.723 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -34.45 14.64 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.548 ' HB3' HD22 ' A' ' 491' ' ' LEU . 68.9 m-85 -141.07 134.88 30.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -153.3 113.8 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.85 143.14 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -103.9 -27.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -54.61 -40.49 68.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -126.57 -38.16 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.32 12.98 4.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 157.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.13 145.59 51.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.29 175.8 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 50.2 mt -116.61 -25.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -116.31 167.93 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -72.21 -55.75 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -32.58 55.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.0 m -64.67 -27.18 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -81.62 -54.8 5.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.7 mt -52.0 -37.45 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -51.93 -33.96 39.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.01 -34.77 78.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -117.93 35.53 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.57 -46.13 2.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -118.7 -43.09 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.855 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 5.1 mttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -34.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.564 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -143.04 132.41 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -151.91 118.02 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.92 143.07 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.2 -27.11 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.83 -37.54 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.41 -39.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.82 13.2 4.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 157.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 143.58 51.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -146.63 171.73 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.1 mt -114.41 -24.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -114.6 170.87 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -78.51 -49.02 14.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -35.68 76.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.1 t -62.15 -26.65 68.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.6 tp -78.67 -54.97 5.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 76.6 mt -51.97 -36.01 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -51.93 -64.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -36.09 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.67 -37.02 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -113.0 33.12 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.27 -65.68 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -96.49 -45.29 6.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.89 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.514 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 29.8 mttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.607 0.717 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -32.87 17.77 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.338 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -137.7 127.2 24.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -150.19 118.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.8 t -51.89 142.25 15.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.88 -27.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -57.75 -27.64 63.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.4 p -136.76 -41.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.11 13.48 4.0 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 156.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.514 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.58 144.44 51.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.88 -178.56 6.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.0 mt -118.93 -31.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -113.68 168.78 9.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -73.41 -54.51 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -31.97 48.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.144 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.1 m -65.46 -34.37 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.67 -53.18 11.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.71 -37.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -51.83 -63.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.96 -32.4 33.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.72 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -113.99 35.26 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.74 -63.36 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.99 -45.12 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.905 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.547 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 19.0 mttp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.577 0.703 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -33.1 16.97 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.439 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.7 m-85 -138.38 128.42 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.5 118.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 31.4 t -51.9 142.55 15.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.25 -27.06 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.05 -25.64 61.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.04 -41.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.07 13.89 3.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.92 156.46 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.547 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -126.89 144.65 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.2 179.48 7.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.45 -30.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.56 171.35 7.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -75.2 -52.65 10.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.6 t -55.59 -29.5 59.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.83 -29.05 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -79.51 -53.66 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 70.1 mt -51.71 -37.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -52.25 -63.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -52.16 -32.49 36.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.58 -37.92 89.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -114.47 35.57 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.04 -62.44 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -100.87 -43.79 5.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.474 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 26.9 mttp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.561 0.696 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -33.01 17.77 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.755 2.303 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.423 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.1 m-85 -136.79 125.14 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.01 118.21 6.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.8 142.77 14.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.1 -27.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -56.91 -33.84 67.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -131.16 -39.92 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.81 13.13 4.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -51.79 156.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.474 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.55 145.54 51.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -147.83 -175.58 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 56.8 mt -121.18 -34.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -108.49 179.83 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -84.0 -55.37 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -31.63 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.4 p -65.64 -41.33 92.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -67.07 -54.35 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.72 -38.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -51.83 -62.37 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -52.6 -30.83 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -66.14 -37.16 85.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -115.36 35.91 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.33 -60.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -102.73 -45.36 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.835 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.532 0.682 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -33.13 17.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.383 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.443 ' HB3' HD22 ' A' ' 491' ' ' LEU . 64.4 m-85 -143.12 132.91 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.67 115.58 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.2 t -51.93 143.09 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.8 pt -103.25 -27.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -54.21 -41.39 68.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.84 -37.9 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.45 13.09 4.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -51.69 157.25 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 141.25 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.83 169.21 18.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 55.8 mt -111.19 -24.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -116.26 176.19 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.42 -56.27 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.71 -34.23 51.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 48.2 m -63.74 -31.69 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.1 tp -74.76 -54.35 7.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 62.7 mt -51.68 -37.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -52.01 -64.27 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -51.51 -39.33 57.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -57.79 -33.91 69.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -117.94 35.22 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.73 -56.04 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.28 -22.67 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.784 ' HE3' ' HB1' ' A' ' 484' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.595 0.712 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.71 17.99 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -130.43 126.83 37.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -151.81 117.71 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 38.2 t -51.93 143.85 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.72 -27.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.07 -31.86 65.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -133.49 -40.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.37 13.22 3.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -51.76 157.68 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.784 ' HB1' ' HE3' ' A' ' 474' ' ' LYS . . . -129.46 143.64 50.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -146.47 175.53 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.7 -24.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 170.81 8.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -79.28 -43.0 24.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.5 p -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 2.8 t -71.28 -27.1 63.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.12 -55.31 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 68.9 mt -51.55 -37.54 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -51.92 -63.51 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.87 -34.15 39.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.65 -37.48 87.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -112.02 34.37 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.87 -66.37 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -95.69 -48.45 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.538 0.685 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.82 17.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.517 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.8 m-85 -144.03 131.25 20.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.5 116.76 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.7 t -51.91 143.63 13.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.9 pt -104.03 -27.58 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -54.77 -38.99 67.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -127.92 -38.58 1.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.61 13.16 4.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -51.85 157.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.05 51.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -147.77 173.22 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.72 -24.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.04 176.17 5.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.99 -54.13 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.93 -25.63 44.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.7 m -72.67 -26.71 61.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.5 tp -80.72 -54.1 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.3 mt -51.72 -38.12 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -51.72 -63.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -51.77 -37.19 50.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.13 -36.26 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -116.12 36.96 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.38 -62.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -97.96 -25.98 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.542 0.687 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.67 18.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -137.04 126.2 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -145.09 116.46 8.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.4 t -51.92 143.06 14.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.6 pt -103.23 -27.33 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.71 -38.6 67.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.6 p -128.36 -38.54 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.86 13.23 4.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -51.91 157.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.79 144.62 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.31 176.26 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.25 -24.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -118.56 174.28 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.43 -53.58 6.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.89 -26.23 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.9 m -72.5 -26.96 61.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.1 tp -81.21 -53.24 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.957 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.4 mt -51.75 -38.52 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -51.75 -63.35 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -51.83 -37.02 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.09 -34.63 73.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 -117.62 36.52 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -127.22 -57.37 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.41 -25.26 12.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.875 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 23.0 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -32.65 18.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.479 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.6 m-85 -144.36 129.26 18.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.22 117.22 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 20.9 t -52.26 142.52 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -102.91 -27.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -53.89 -39.94 66.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.9 p -127.14 -38.15 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.53 13.37 4.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -52.28 157.04 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.04 142.83 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.99 170.58 16.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.84 -24.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -114.29 174.75 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.57 -38.25 18.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 6.9 p -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.8 t -74.43 -26.84 60.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -77.25 -55.73 5.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.8 mt -51.62 -38.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.198 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -52.15 -63.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -51.7 -36.4 46.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.29 -35.18 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -117.34 35.22 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -126.57 -58.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.89 -25.64 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.511 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 25.6 mttp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.606 0.717 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -33.03 17.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.433 ' HB3' HD22 ' A' ' 491' ' ' LEU . 67.4 m-85 -137.05 127.69 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -149.98 118.72 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.87 143.12 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.3 -27.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -56.59 -32.72 65.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -132.32 -40.13 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.98 13.26 4.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -51.89 156.68 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.511 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.14 143.83 51.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -146.46 -177.83 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.79 -32.46 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -111.69 173.85 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -77.17 -54.74 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.8 t -54.25 -30.12 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.4 m -67.51 -29.91 69.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.9 tp -79.34 -53.54 6.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.98 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.3 mt -51.73 -38.02 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -51.87 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -51.87 -31.88 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.835 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.66 -36.96 85.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -115.04 36.39 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.18 -62.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.54 -45.51 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.851 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.504 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 35.8 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.571 0.701 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -33.04 17.19 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.477 ' HB3' HD22 ' A' ' 491' ' ' LEU . 56.4 m-85 -138.26 128.44 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.19 118.29 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.9 t -51.88 140.52 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 6.9 pt -101.47 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.91 -30.22 63.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.41 -40.48 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.96 14.17 3.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.448 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.62 156.14 2.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.504 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.37 144.05 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.0 -179.21 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.47 -30.85 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -113.66 173.95 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -77.42 -55.37 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.4 t -53.22 -29.94 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.176 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.4 m -67.73 -32.6 73.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.3 tp -76.01 -53.7 7.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.1 mt -52.42 -37.25 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -51.96 -64.22 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -51.94 -30.63 25.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -67.8 -36.68 80.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -115.9 38.74 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.99 -51.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.73 -47.15 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.548 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 24.5 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.565 0.698 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.73 17.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.406 ' HB3' HD22 ' A' ' 491' ' ' LEU . 54.9 m-85 -135.91 127.14 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -150.2 119.15 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 37.5 t -51.95 142.74 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.11 -27.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -57.35 -28.27 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.71 -40.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.36 13.43 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 156.01 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.548 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.65 143.32 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -145.23 -175.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 65.3 mt -119.68 -35.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -109.77 -179.59 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.87 -54.81 4.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.8 p -51.82 -30.69 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.4 p -67.09 -39.46 86.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 476' ' ' TYR . 17.0 tp -69.18 -45.95 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.97 -38.45 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -61.89 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -53.35 -30.41 39.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -67.42 -35.95 80.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -115.11 33.73 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.94 -61.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -100.95 -45.11 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.57 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 41.6 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.86 17.73 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.332 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.407 ' HB3' HD22 ' A' ' 491' ' ' LEU . 65.6 m-85 -137.61 125.45 22.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -147.58 119.28 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 47.5 t -51.89 145.04 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -104.44 -27.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.18 -34.57 66.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.0 p -131.47 -39.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.95 13.98 3.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 156.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.57 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.2 144.81 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.15 -178.06 6.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.44 -31.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.35 -177.38 3.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.73 -52.72 5.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -25.91 59.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -72.81 -28.23 62.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 476' ' ' TYR . 15.3 tp -79.38 -51.71 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.7 mt -51.66 -38.11 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -51.89 -61.14 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -54.77 -26.81 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.25 -31.19 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -118.41 31.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -119.34 -52.62 2.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.48 -48.38 2.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.554 0.692 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -33.0 17.39 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.31 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.41 ' HB3' HD22 ' A' ' 491' ' ' LEU . 57.1 m-85 -137.75 129.06 27.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -151.65 118.12 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 34.1 t -51.93 142.65 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.25 -27.22 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.03 -24.53 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -140.15 -41.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.01 3.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 156.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.334 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.21 142.33 51.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.126 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -145.15 -179.12 6.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.42 -34.58 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -109.41 175.96 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.43 -51.32 9.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -33.46 65.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -32.89 74.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.9 tp -75.69 -54.22 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 78.4 mt -51.7 -37.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -52.09 -63.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -51.97 -32.68 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -65.14 -36.08 83.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -116.03 35.58 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.98 -47.4 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -117.72 -46.81 2.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.519 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 28.9 mttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.571 0.7 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.67 18.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.375 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.483 ' HB3' HD22 ' A' ' 491' ' ' LEU . 59.4 m-85 -139.14 128.36 24.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.97 118.81 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.8 t -52.07 141.29 18.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.96 -26.98 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -56.8 -32.1 65.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.4 p -132.69 -40.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.78 14.07 3.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 156.31 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.727 0.298 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.34 144.72 51.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -147.12 179.67 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.87 -31.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -113.2 175.43 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.56 -53.73 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.4 t -54.51 -29.31 50.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.9 -29.95 68.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.8 tp -79.21 -54.61 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.57 -37.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -52.03 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -52.54 -29.38 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -70.22 -35.49 73.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -115.86 39.85 2.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -127.54 -54.09 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -112.98 -47.14 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.929 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.495 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 30.4 mttt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.579 0.704 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -32.65 18.27 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 491' ' ' LEU . 74.7 m-85 -139.03 127.28 22.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.972 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -148.2 116.93 6.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 17.4 t -52.11 139.94 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.72 -27.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.0 -37.99 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.2 p -128.51 -38.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.03 13.21 4.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -52.87 157.12 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.97 143.79 50.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -146.42 -178.76 6.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.4 mt -119.21 -31.24 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -112.97 161.55 16.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -67.12 -55.32 14.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.7 t -53.45 -30.85 42.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 47.1 m -67.05 -30.98 71.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.0 tp -76.83 -53.68 7.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.47 -37.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -51.56 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -51.78 -35.28 43.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -61.32 -35.62 77.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -115.76 32.48 6.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.22 -65.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -95.12 -25.56 16.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 179.933 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.0 mptt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.605 0.716 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.89 124.25 21.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.23 118.42 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.5 t -52.03 142.87 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -103.37 -27.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -57.56 -28.01 63.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -136.59 -40.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.89 13.84 3.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 156.19 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.1 146.15 50.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -148.1 -177.3 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.78 -33.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -112.85 175.96 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -78.61 -53.5 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.6 t -54.91 -26.59 37.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -71.89 -30.01 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.48 -53.97 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.65 -37.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -51.8 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -52.93 -29.44 28.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -68.99 -36.34 77.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -113.45 32.86 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.33 -64.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -96.05 -50.55 4.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.849 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 14.8 mttm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.557 0.694 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.84 17.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.431 ' HB3' HD22 ' A' ' 491' ' ' LEU . 60.3 m-85 -143.9 130.99 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -151.63 115.38 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 19.5 t -51.88 140.19 20.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.26 -27.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -54.66 -34.82 62.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.71 -39.66 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.69 12.94 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.51 156.07 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.54 140.75 52.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -143.17 173.98 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.26 -25.09 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.09 170.81 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -76.35 -54.7 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.3 p -55.9 -25.37 42.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.7 t -72.37 -28.2 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.8 tp -80.05 -54.82 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.61 -35.14 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -53.92 -64.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -52.13 -34.96 46.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.36 -33.38 74.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -118.71 32.38 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.88 -47.4 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -116.6 -26.18 7.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.728 ' HD2' ' HB1' ' A' ' 484' ' ' ALA . 10.1 mttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.522 0.677 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.07 17.42 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.526 ' HB3' HD22 ' A' ' 491' ' ' LEU . 62.5 m-85 -141.39 130.91 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -151.69 117.68 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.56 142.85 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.54 -27.35 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -57.84 -23.62 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -141.26 -41.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.45 3.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.505 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.47 156.44 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 474' ' ' LYS . . . -127.47 142.07 51.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -144.79 172.6 12.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.19 -25.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -116.84 173.94 6.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -77.31 -54.6 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.1 t -53.5 -30.54 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 9.3 m -67.08 -31.08 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.9 tp -77.87 -57.64 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -51.5 -35.96 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -53.3 -63.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -33.21 34.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -63.66 -36.63 84.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -116.37 34.95 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.99 -44.51 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -119.66 -46.68 2.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 23.3 p -174.4 145.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 110.811 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.5 m -165.09 144.24 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 176.96 -157.23 22.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 5.5 m -147.17 120.08 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 41.1 t -92.37 112.61 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.11 28.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 12.1 t -171.7 142.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -69.32 137.49 29.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.75 160.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -139.67 160.69 60.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.618 0.723 . . . . 0.0 110.823 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -34.45 14.64 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.548 ' HB3' HD22 ' A' ' 491' ' ' LEU . 68.9 m-85 -141.07 134.88 30.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -153.3 113.8 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.85 143.14 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -103.9 -27.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -54.61 -40.49 68.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -126.57 -38.16 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.32 12.98 4.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 157.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.13 145.59 51.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.29 175.8 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 50.2 mt -116.61 -25.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -116.31 167.93 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -72.21 -55.75 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -32.58 55.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.0 m -64.67 -27.18 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -81.62 -54.8 5.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.7 mt -52.0 -37.45 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -51.93 -33.96 39.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.01 -34.77 78.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -117.93 35.53 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.57 -46.13 2.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -118.7 -43.09 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -61.46 -72.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.3 p -96.07 25.6 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -103.63 -131.14 7.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -79.59 147.69 31.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 52.55 73.31 0.97 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.555 0.693 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.273 . . . . 0.0 112.288 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 39.6 t -108.77 98.91 8.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -163.49 -73.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 140.8 43.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 8.5 p -119.79 28.63 8.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 34.0 p -53.92 163.83 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.883 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 CA-C-O 119.125 -0.82 . . . . 0.0 112.515 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 30.4 p -121.47 163.03 19.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 m -136.02 138.57 42.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -70.74 132.69 22.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 30.5 t -96.71 -35.86 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.814 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 43.0 t -127.3 96.75 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -138.86 97.2 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 6.3 t -125.75 125.2 42.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.8 0.333 . . . . 0.0 111.133 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 131.44 173.98 13.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -107.11 136.09 47.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -128.62 160.61 61.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -34.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.564 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -143.04 132.41 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -151.91 118.02 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.92 143.07 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.2 -27.11 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.83 -37.54 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.41 -39.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.82 13.2 4.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 157.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 143.58 51.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -146.63 171.73 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.1 mt -114.41 -24.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -114.6 170.87 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -78.51 -49.02 14.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -35.68 76.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.1 t -62.15 -26.65 68.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.6 tp -78.67 -54.97 5.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 76.6 mt -51.97 -36.01 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -51.93 -64.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -36.09 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' TRP . . . . . 0.482 ' O ' HG22 ' A' ' 500' ' ' THR . 1.1 t-105 -62.67 -37.02 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -113.0 33.12 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.27 -65.68 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -96.49 -45.29 6.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -60.11 -70.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 495' ' ' TRP . 15.1 t -129.38 172.3 11.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -167.21 176.16 42.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.491 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -114.91 34.87 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -147.28 73.43 11.91 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -27.15 26.58 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.278 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 1.8 p -76.64 81.42 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -175.19 170.27 43.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -16.87 37.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 77.1 p -84.88 123.21 30.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.4 m -85.65 -31.15 22.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.467 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 60.8 p -161.19 117.8 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 38.9 m -114.43 173.83 6.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 144.38 110.3 0.7 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 10.5 t -167.53 154.73 8.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 37.5 m -145.05 169.4 18.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -153.53 91.7 0.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 9.9 t -88.68 -28.97 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.13 150.97 28.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -122.32 154.05 38.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.514 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 29.8 mttt -113.16 160.65 30.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.717 . . . . 0.0 110.857 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -32.87 17.77 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.338 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -137.7 127.2 24.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -150.19 118.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.8 t -51.89 142.25 15.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.88 -27.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -57.75 -27.64 63.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.4 p -136.76 -41.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.11 13.48 4.0 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 156.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.514 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.58 144.44 51.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.88 -178.56 6.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.0 mt -118.93 -31.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -113.68 168.78 9.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -73.41 -54.51 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -31.97 48.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.144 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.1 m -65.46 -34.37 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.67 -53.18 11.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.71 -37.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -51.83 -63.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.96 -32.4 33.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.72 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -113.99 35.26 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.74 -63.36 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.99 -45.12 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -57.65 -67.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.905 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.2 p -106.28 160.49 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 131.83 -179.16 17.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.55 39.42 2.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 110.896 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 160.32 69.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 80.42 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.721 2.281 . . . . 0.0 112.311 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 27.2 p -53.13 -58.33 7.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 171.41 -73.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 176.8 6.27 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.712 2.275 . . . . 0.0 112.38 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 58.4 m -62.38 144.59 55.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.835 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 23.0 m -136.54 126.9 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.485 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 34.9 p -60.76 140.65 57.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.1 t -133.2 -51.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 172.37 -30.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 53.0 m -65.69 113.51 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.884 0.373 . . . . 0.0 110.82 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 66.4 p -105.5 172.64 6.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.81 92.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.1 p -65.33 174.44 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.352 . . . . 0.0 111.115 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 74.81 135.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -158.55 126.94 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.547 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 19.0 mttp -130.05 160.7 64.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.577 0.703 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -33.1 16.97 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.439 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.7 m-85 -138.38 128.42 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.5 118.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 31.4 t -51.9 142.55 15.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.25 -27.06 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.05 -25.64 61.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.04 -41.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.07 13.89 3.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.92 156.46 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.547 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -126.89 144.65 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.2 179.48 7.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.45 -30.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.56 171.35 7.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -75.2 -52.65 10.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.6 t -55.59 -29.5 59.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.83 -29.05 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -79.51 -53.66 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 70.1 mt -51.71 -37.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -52.25 -63.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -52.16 -32.49 36.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.58 -37.92 89.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -114.47 35.57 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.04 -62.44 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -100.87 -43.79 5.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.41 -66.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.3 p -108.83 139.7 43.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 164.87 -117.01 0.73 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -87.8 81.99 7.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp 63.05 160.64 0.12 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -16.41 37.29 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.367 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 1.5 t 52.91 55.61 8.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 165.09 67.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 130.82 19.9 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.682 2.254 . . . . 0.0 112.339 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 32.8 t -157.14 164.9 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 11.6 t -124.42 42.58 3.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.82 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.49 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 31.1 t -165.08 128.17 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 36.6 p -94.72 -176.53 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.39 147.45 18.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 14.9 m -139.61 154.13 47.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.825 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 3.0 p -140.05 137.88 34.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.853 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.77 -142.83 4.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 23.6 p -111.66 123.36 50.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.166 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.93 99.41 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -103.1 56.88 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.474 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 26.9 mttp -117.26 160.62 36.8 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.561 0.696 . . . . 0.0 110.939 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -33.01 17.77 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.755 2.303 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.423 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.1 m-85 -136.79 125.14 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.01 118.21 6.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.8 142.77 14.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.1 -27.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -56.91 -33.84 67.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -131.16 -39.92 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.81 13.13 4.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -51.79 156.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.474 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.55 145.54 51.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -147.83 -175.58 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 56.8 mt -121.18 -34.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -108.49 179.83 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -84.0 -55.37 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -31.63 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.4 p -65.64 -41.33 92.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -67.07 -54.35 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.72 -38.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -51.83 -62.37 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -52.6 -30.83 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -66.14 -37.16 85.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -115.36 35.91 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.33 -60.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -102.73 -45.36 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.46 -68.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.8 p -103.83 38.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -133.91 -60.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.07 128.03 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -101.56 160.7 25.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.544 0.687 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.42 0.9 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 20.3 m -115.39 -30.22 6.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -92.14 -175.83 42.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 130.94 20.29 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.389 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 5.4 t -132.64 116.22 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 48.1 t -115.33 124.83 52.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.508 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 58.1 m -91.17 -60.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.811 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 1.4 t -87.68 128.57 35.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -86.4 -168.07 44.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 40.7 t -165.16 148.45 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.849 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 46.0 p -106.07 120.09 40.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.55 124.81 3.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 43.0 p -115.66 123.68 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.71 151.09 26.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.23 156.4 31.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -128.1 160.57 61.01 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.532 0.682 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -33.13 17.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.383 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.443 ' HB3' HD22 ' A' ' 491' ' ' LEU . 64.4 m-85 -143.12 132.91 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.67 115.58 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.2 t -51.93 143.09 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.8 pt -103.25 -27.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -54.21 -41.39 68.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.84 -37.9 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.45 13.09 4.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -51.69 157.25 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 141.25 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.83 169.21 18.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 55.8 mt -111.19 -24.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -116.26 176.19 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.42 -56.27 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.71 -34.23 51.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 48.2 m -63.74 -31.69 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.1 tp -74.76 -54.35 7.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 62.7 mt -51.68 -37.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -52.01 -64.27 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -51.51 -39.33 57.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -57.79 -33.91 69.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -117.94 35.22 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.73 -56.04 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.28 -22.67 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -90.14 -62.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 10.2 p -120.06 -172.45 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.107 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 95.4 -120.39 6.5 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.451 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -58.23 98.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -130.37 72.39 81.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.625 0.726 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.73 4.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 26.2 p -107.45 96.41 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -66.63 -72.2 0.8 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 103.42 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 1.7 t -70.58 108.23 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.9 t -83.8 93.5 7.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.496 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 16.2 t -169.1 132.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.367 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.3 t -159.78 160.93 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.44 39.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 3.7 m -123.01 167.58 13.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 95.7 p -59.92 114.97 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 158.74 -67.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 4.0 t -62.04 155.16 24.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -153.71 -98.33 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.49 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -168.88 166.5 11.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.784 ' HE3' ' HB1' ' A' ' 484' ' ' ALA . 0.0 OUTLIER -108.03 160.68 26.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.863 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.71 17.99 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -130.43 126.83 37.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -151.81 117.71 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 38.2 t -51.93 143.85 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.72 -27.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.07 -31.86 65.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -133.49 -40.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.37 13.22 3.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -51.76 157.68 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.784 ' HB1' ' HE3' ' A' ' 474' ' ' LYS . . . -129.46 143.64 50.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -146.47 175.53 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.7 -24.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 170.81 8.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -79.28 -43.0 24.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.5 p -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 2.8 t -71.28 -27.1 63.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.12 -55.31 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 68.9 mt -51.55 -37.54 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -51.92 -63.51 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.87 -34.15 39.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' TRP . . . . . 0.426 ' O ' HG22 ' A' ' 500' ' ' THR . 1.2 t-105 -64.65 -37.48 87.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -112.02 34.37 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.87 -66.37 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -95.69 -48.45 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -56.54 -72.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 495' ' ' TRP . 9.2 t -126.3 164.1 21.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.177 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.66 31.37 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.463 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -114.21 35.57 4.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -127.92 160.66 60.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.557 0.694 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 89.52 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.318 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 9.3 p -107.79 -43.94 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 138.14 -167.22 25.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 126.51 13.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.358 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 36.3 p -124.74 71.74 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 4.2 m -100.5 145.53 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.848 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.501 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.1 m -140.91 133.61 28.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.898 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 52.7 p -114.67 131.53 56.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 178.78 116.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 4.6 m -131.2 130.84 43.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.823 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 97.0 p -84.84 174.93 9.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.815 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 101.18 67.33 0.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 13.1 m -116.88 74.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.131 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -170.83 115.34 0.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -81.14 129.21 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -129.84 159.1 71.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.82 17.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.517 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.8 m-85 -144.03 131.25 20.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.5 116.76 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.7 t -51.91 143.63 13.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.9 pt -104.03 -27.58 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -54.77 -38.99 67.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -127.92 -38.58 1.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.61 13.16 4.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -51.85 157.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.05 51.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -147.77 173.22 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.72 -24.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.04 176.17 5.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.99 -54.13 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.93 -25.63 44.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.7 m -72.67 -26.71 61.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.5 tp -80.72 -54.1 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.3 mt -51.72 -38.12 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -51.72 -63.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -51.77 -37.19 50.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.13 -36.26 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -116.12 36.96 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.38 -62.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -97.96 -25.98 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -83.65 -64.95 1.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 12.2 p -116.2 123.19 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 164.45 -146.87 11.85 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.63 133.15 35.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.21 73.69 0.83 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.562 0.696 . . . . 0.0 110.86 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 124.99 11.64 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.644 2.23 . . . . 0.0 112.372 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 37.4 t -127.86 150.38 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 174.93 167.15 33.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 93.96 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.353 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 12.7 t -69.47 -37.92 77.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.18 126.52 35.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.519 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 45.3 t -124.99 105.56 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 42.1 m -71.41 122.7 20.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -176.44 -101.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 5.1 t -109.88 29.73 7.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.874 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 85.4 p -139.75 -178.49 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 156.04 -84.25 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 8.9 t -137.52 142.63 41.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.135 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -68.79 -115.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.73 31.08 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -131.78 160.75 66.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.542 0.687 . . . . 0.0 110.922 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.67 18.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -137.04 126.2 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -145.09 116.46 8.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.4 t -51.92 143.06 14.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.6 pt -103.23 -27.33 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.71 -38.6 67.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.6 p -128.36 -38.54 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.86 13.23 4.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -51.91 157.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.79 144.62 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.31 176.26 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.25 -24.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -118.56 174.28 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.43 -53.58 6.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.89 -26.23 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.9 m -72.5 -26.96 61.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.1 tp -81.21 -53.24 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.957 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.4 mt -51.75 -38.52 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -51.75 -63.35 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -51.83 -37.02 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.09 -34.63 73.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 -117.62 36.52 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -127.22 -57.37 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.41 -25.26 12.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -84.04 -63.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 11.9 p -116.35 -172.63 2.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 107.08 101.2 2.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 54.53 36.61 26.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -114.45 160.06 34.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.575 0.702 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 163.6 37.68 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.371 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 46.9 m -157.54 127.85 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 174.87 69.05 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 168.77 20.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.636 2.224 . . . . 0.0 112.318 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 21.7 t -104.48 151.3 23.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 59.6 p -171.43 156.38 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.476 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.5 t -159.37 145.25 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 48.9 p -166.95 124.51 1.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.838 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 173.03 119.97 0.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 1.8 p -105.54 137.96 42.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 4.2 p -92.88 53.76 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 143.07 149.13 5.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.455 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 40.0 p -146.39 115.53 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.348 . . . . 0.0 111.129 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -108.23 -159.1 19.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.2 -178.0 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -156.34 160.65 30.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -32.65 18.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.479 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.6 m-85 -144.36 129.26 18.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.22 117.22 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 20.9 t -52.26 142.52 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -102.91 -27.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -53.89 -39.94 66.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.9 p -127.14 -38.15 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.53 13.37 4.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -52.28 157.04 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.04 142.83 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.99 170.58 16.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.84 -24.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -114.29 174.75 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.57 -38.25 18.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 6.9 p -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.8 t -74.43 -26.84 60.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -77.25 -55.73 5.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.8 mt -51.62 -38.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.198 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -52.15 -63.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -51.7 -36.4 46.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.29 -35.18 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -117.34 35.22 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -126.57 -58.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.89 -25.64 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -84.27 -69.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 11.9 p -109.37 37.31 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -125.93 20.93 6.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -163.09 128.52 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -52.37 160.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 120.24 7.05 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 4.4 m -108.1 156.32 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -55.75 -73.47 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 129.16 17.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 0.0 112.376 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 2.2 m -169.65 168.82 8.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 3.4 m -81.52 -55.38 4.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.448 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 79.7 p -171.4 129.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 50.3 m -111.37 170.35 8.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.05 41.74 2.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.0 m -74.05 118.54 17.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 3.3 p -138.94 152.6 47.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.12 146.42 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.7 m -89.43 122.94 33.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.115 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 105.26 167.23 23.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 175.09 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.511 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 25.6 mttp -144.01 160.68 48.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.606 0.717 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -33.03 17.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.433 ' HB3' HD22 ' A' ' 491' ' ' LEU . 67.4 m-85 -137.05 127.69 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -149.98 118.72 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.87 143.12 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.3 -27.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -56.59 -32.72 65.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -132.32 -40.13 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.98 13.26 4.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -51.89 156.68 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.511 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.14 143.83 51.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -146.46 -177.83 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.79 -32.46 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -111.69 173.85 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -77.17 -54.74 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.8 t -54.25 -30.12 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.4 m -67.51 -29.91 69.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.9 tp -79.34 -53.54 6.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.98 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.3 mt -51.73 -38.02 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -51.87 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -51.87 -31.88 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.835 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.66 -36.96 85.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -115.04 36.39 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.18 -62.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.54 -45.51 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -57.52 -65.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.2 p -109.5 161.94 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 130.09 -103.36 0.57 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.484 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -120.45 142.97 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm 51.84 68.15 3.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.567 0.699 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 97.67 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.715 2.276 . . . . 0.0 112.328 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.84 165.06 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 167.82 73.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -19.71 36.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.255 . . . . 0.0 112.391 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 36.0 p -80.44 174.92 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 63.0 p -130.67 102.77 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.15 -0.805 . . . . 0.0 112.485 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 97.9 p -137.09 161.59 35.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 8.2 t -126.55 131.87 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.12 160.62 28.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 15.3 t -165.8 132.19 2.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 2.8 p -151.75 165.29 34.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 155.06 97.27 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.3 p -126.58 122.53 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.12 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -172.37 139.76 5.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.523 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -89.04 90.07 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.504 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 35.8 mttt -102.11 160.66 25.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.701 . . . . 0.0 110.914 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -33.04 17.19 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.477 ' HB3' HD22 ' A' ' 491' ' ' LEU . 56.4 m-85 -138.26 128.44 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.19 118.29 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.9 t -51.88 140.52 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 6.9 pt -101.47 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.91 -30.22 63.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.41 -40.48 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.96 14.17 3.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.448 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.62 156.14 2.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.504 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.37 144.05 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.0 -179.21 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.47 -30.85 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -113.66 173.95 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -77.42 -55.37 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.4 t -53.22 -29.94 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.176 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.4 m -67.73 -32.6 73.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.3 tp -76.01 -53.7 7.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.1 mt -52.42 -37.25 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -51.96 -64.22 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -51.94 -30.63 25.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' TRP . . . . . 0.578 ' O ' HG23 ' A' ' 500' ' ' THR . 1.1 t-105 -67.8 -36.68 80.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -115.9 38.74 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.99 -51.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.73 -47.15 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -51.62 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 495' ' ' TRP . 36.7 p -60.01 177.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 53.76 -149.06 15.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -71.68 139.13 49.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -69.36 160.55 78.63 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.591 0.71 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -20.36 35.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.633 2.222 . . . . 0.0 112.4 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 8.4 t -168.52 177.77 5.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.28 19.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 90.12 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.682 2.255 . . . . 0.0 112.333 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 42.8 m -105.27 134.55 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 84.1 p -60.38 -28.68 68.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.484 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.6 t 52.11 33.9 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 35.9 m -121.22 167.52 12.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 56.6 79.0 0.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 79.6 p -142.95 143.24 31.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 5.6 m -134.57 167.05 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -155.19 -75.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 8.8 t -114.38 142.29 46.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.149 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.99 -131.07 5.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -37.56 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.548 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 24.5 mttt -60.57 160.71 17.38 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.565 0.698 . . . . 0.0 110.908 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.73 17.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.406 ' HB3' HD22 ' A' ' 491' ' ' LEU . 54.9 m-85 -135.91 127.14 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -150.2 119.15 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 37.5 t -51.95 142.74 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.11 -27.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -57.35 -28.27 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.71 -40.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.36 13.43 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 156.01 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.548 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.65 143.32 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -145.23 -175.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 65.3 mt -119.68 -35.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -109.77 -179.59 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.87 -54.81 4.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.8 p -51.82 -30.69 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.4 p -67.09 -39.46 86.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 476' ' ' TYR . 17.0 tp -69.18 -45.95 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.97 -38.45 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -61.89 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -53.35 -30.41 39.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -67.42 -35.95 80.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -115.11 33.73 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.94 -61.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -100.95 -45.11 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -59.29 -74.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 14.7 t -126.4 172.42 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 176.33 -73.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -136.05 132.99 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.937 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp 51.88 68.16 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.588 0.709 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -30.14 22.73 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.321 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 3.0 p -59.46 167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -151.71 176.79 29.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -27.69 26.22 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 50.6 m -85.9 162.96 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 22.9 t -132.55 34.12 3.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.508 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 39.3 m -119.13 159.07 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.351 . . . . 0.0 110.889 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.6 t -119.29 149.08 42.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 139.09 122.88 2.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.4 m -126.76 85.74 2.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 1.3 t -111.73 155.23 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 148.74 -103.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.453 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 17.4 p -52.18 122.9 9.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.34 . . . . 0.0 111.162 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.58 -179.48 40.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.71 175.46 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.57 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 41.6 mttt -137.69 160.7 63.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.86 17.73 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.332 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.407 ' HB3' HD22 ' A' ' 491' ' ' LEU . 65.6 m-85 -137.61 125.45 22.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -147.58 119.28 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 47.5 t -51.89 145.04 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -104.44 -27.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.18 -34.57 66.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.0 p -131.47 -39.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.95 13.98 3.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 156.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.57 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.2 144.81 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.15 -178.06 6.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.44 -31.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.35 -177.38 3.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.73 -52.72 5.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -25.91 59.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -72.81 -28.23 62.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 476' ' ' TYR . 15.3 tp -79.38 -51.71 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.7 mt -51.66 -38.11 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -51.89 -61.14 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -54.77 -26.81 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.25 -31.19 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -118.41 31.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -119.34 -52.62 2.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.48 -48.38 2.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -53.94 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 13.4 p -108.87 24.22 13.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -105.29 178.27 23.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.76 157.73 37.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -147.8 160.68 37.55 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -37.53 9.05 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.318 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 12.7 p -77.81 145.93 36.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -129.4 178.68 17.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 107.7 1.92 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.676 2.251 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 30.8 p -131.58 161.44 32.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.8 p -52.36 -48.65 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.493 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.6 p -69.39 167.51 16.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.344 . . . . 0.0 110.886 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.9 t -170.38 169.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -155.63 -173.82 24.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.6 m -126.86 56.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 1.1 p -105.41 81.76 1.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -71.74 111.48 3.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 9.7 t -78.3 155.58 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 138.67 101.32 0.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.489 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -100.94 114.48 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -120.24 159.3 48.1 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -33.0 17.39 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.31 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.41 ' HB3' HD22 ' A' ' 491' ' ' LEU . 57.1 m-85 -137.75 129.06 27.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -151.65 118.12 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 34.1 t -51.93 142.65 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.25 -27.22 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.03 -24.53 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -140.15 -41.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.01 3.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 156.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.334 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.21 142.33 51.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.126 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -145.15 -179.12 6.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.42 -34.58 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -109.41 175.96 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.43 -51.32 9.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -33.46 65.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -32.89 74.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.9 tp -75.69 -54.22 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 78.4 mt -51.7 -37.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -52.09 -63.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -51.97 -32.68 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -65.14 -36.08 83.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -116.03 35.58 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.98 -47.4 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -117.72 -46.81 2.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -57.2 -73.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.6 p -94.4 -33.6 13.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.85 5.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -84.83 163.13 19.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -101.7 159.29 29.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.92 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.697 2.264 . . . . 0.0 112.383 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 2.8 m -129.27 29.11 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -173.59 179.89 44.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 137.12 34.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.656 2.238 . . . . 0.0 112.31 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 7.5 t -125.62 43.46 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 13.7 m -128.9 62.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.836 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.458 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 19.4 t -123.47 70.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.4 t -92.94 163.7 13.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -133.77 76.66 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 4.3 t -153.52 137.77 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 9.2 m -116.97 122.5 44.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -84.84 -167.8 43.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 5.2 t -172.75 139.35 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 156.65 151.7 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -86.37 93.83 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.887 0.375 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.519 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 28.9 mttt -107.6 160.74 25.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.571 0.7 . . . . 0.0 110.939 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.67 18.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.375 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.483 ' HB3' HD22 ' A' ' 491' ' ' LEU . 59.4 m-85 -139.14 128.36 24.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.97 118.81 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.8 t -52.07 141.29 18.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.96 -26.98 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -56.8 -32.1 65.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.4 p -132.69 -40.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.78 14.07 3.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 156.31 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.727 0.298 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.34 144.72 51.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -147.12 179.67 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.87 -31.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -113.2 175.43 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.56 -53.73 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.4 t -54.51 -29.31 50.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.9 -29.95 68.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.8 tp -79.21 -54.61 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.57 -37.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -52.03 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -52.54 -29.38 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -70.22 -35.49 73.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -115.86 39.85 2.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -127.54 -54.09 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -112.98 -47.14 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -51.7 -50.09 61.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.5 p -108.58 122.38 46.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 109.52 74.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -83.64 131.04 34.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.393 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -120.48 160.68 42.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.842 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 96.09 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 37.9 t -168.62 144.24 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 144.86 73.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -172.2 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.729 2.286 . . . . 0.0 112.339 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 5.8 p -153.74 148.98 26.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 6.9 p -89.45 130.38 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.145 -0.809 . . . . 0.0 112.514 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 46.0 m -128.25 113.45 15.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.904 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 26.0 p -147.0 112.38 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.821 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -164.89 134.61 3.39 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 6.2 t -171.18 133.18 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.883 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 5.0 m -159.55 169.23 24.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 155.05 133.01 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 34.2 p -119.25 78.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.175 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -138.67 131.78 5.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.52 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 157.6 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.495 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 30.4 mttt -133.48 160.71 67.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.579 0.704 . . . . 0.0 110.875 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -32.65 18.27 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 491' ' ' LEU . 74.7 m-85 -139.03 127.28 22.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.972 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -148.2 116.93 6.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 17.4 t -52.11 139.94 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.72 -27.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.0 -37.99 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.2 p -128.51 -38.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.03 13.21 4.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -52.87 157.12 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.97 143.79 50.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -146.42 -178.76 6.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.4 mt -119.21 -31.24 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -112.97 161.55 16.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -67.12 -55.32 14.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.7 t -53.45 -30.85 42.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 47.1 m -67.05 -30.98 71.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.0 tp -76.83 -53.68 7.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.47 -37.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -51.56 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -51.78 -35.28 43.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -61.32 -35.62 77.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -115.76 32.48 6.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.22 -65.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -95.12 -25.56 16.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -84.85 -71.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.3 p -109.88 122.3 47.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 131.94 -114.5 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -68.87 109.51 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.9 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -59.9 160.69 14.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.534 0.683 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 111.0 2.69 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 47.8 t -58.55 -48.89 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -74.4 -170.34 23.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.94 15.44 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.719 2.28 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 3.9 t -81.85 161.5 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 6.4 m -122.5 -176.53 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.481 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 12.1 t -113.99 -36.44 4.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 110.825 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.7 m -85.29 151.69 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -149.81 -91.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 113.21 25.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.347 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 2.7 t -101.26 136.72 40.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 146.18 146.54 4.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 6.1 p -91.82 127.75 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 -145.53 18.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 150.01 26.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.922 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -91.73 160.7 35.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.716 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.89 124.25 21.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.23 118.42 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.5 t -52.03 142.87 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -103.37 -27.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -57.56 -28.01 63.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -136.59 -40.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.89 13.84 3.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 156.19 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.1 146.15 50.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -148.1 -177.3 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.78 -33.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -112.85 175.96 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -78.61 -53.5 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.6 t -54.91 -26.59 37.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -71.89 -30.01 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.48 -53.97 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.65 -37.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -51.8 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -52.93 -29.44 28.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' TRP . . . . . 0.439 ' O ' HG22 ' A' ' 500' ' ' THR . 1.1 t-105 -68.99 -36.34 77.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -113.45 32.86 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.33 -64.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -96.05 -50.55 4.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -55.13 -74.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 495' ' ' TRP . 9.6 t -124.46 164.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 127.45 -69.33 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -105.77 77.33 1.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.868 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 160.69 0.12 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.543 0.687 . . . . 0.0 110.949 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 128.65 16.33 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.373 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.48 132.41 9.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -173.6 172.08 44.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 122.65 9.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 25.5 p -164.62 120.21 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.3 t -167.86 -176.52 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 34.4 p -132.5 74.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.1 t -128.27 85.04 2.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 164.45 156.94 9.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.443 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 11.1 p -166.3 129.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 30.0 m -76.31 152.56 36.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -111.58 -160.02 15.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.462 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 2.1 t -174.28 121.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 178.98 174.99 45.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.481 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -98.83 124.43 43.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -132.16 160.74 66.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.557 0.694 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.84 17.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.431 ' HB3' HD22 ' A' ' 491' ' ' LEU . 60.3 m-85 -143.9 130.99 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -151.63 115.38 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 19.5 t -51.88 140.19 20.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.26 -27.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -54.66 -34.82 62.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.71 -39.66 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.69 12.94 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.51 156.07 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.54 140.75 52.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -143.17 173.98 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.26 -25.09 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.09 170.81 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -76.35 -54.7 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.3 p -55.9 -25.37 42.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.7 t -72.37 -28.2 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.8 tp -80.05 -54.82 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.61 -35.14 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -53.92 -64.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -52.13 -34.96 46.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.36 -33.38 74.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -118.71 32.38 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.88 -47.4 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -116.6 -26.18 7.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -84.74 -69.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.7 p -107.16 33.32 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -127.35 -70.84 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.55 169.75 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.76 160.7 76.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 127.62 14.85 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 0.0 112.368 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 38.9 m -123.83 60.37 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.56 70.85 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 79.54 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 3.8 m -123.74 101.65 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 10.0 t -63.28 -35.68 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.16 -0.8 . . . . 0.0 112.434 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 14.1 m -78.1 96.09 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.92 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 54.7 p -114.82 176.41 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.31 -61.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.483 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 6.2 p -144.42 166.36 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 29.6 t -97.97 -42.17 7.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 173.65 -155.91 23.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 90.4 m -93.76 107.95 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.176 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.1 174.16 42.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -108.66 109.25 20.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.728 ' HD2' ' HB1' ' A' ' 484' ' ' ALA . 10.1 mttp -67.81 160.67 72.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.522 0.677 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.07 17.42 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.526 ' HB3' HD22 ' A' ' 491' ' ' LEU . 62.5 m-85 -141.39 130.91 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -151.69 117.68 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.56 142.85 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.54 -27.35 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -57.84 -23.62 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -141.26 -41.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.45 3.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.505 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.47 156.44 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 474' ' ' LYS . . . -127.47 142.07 51.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -144.79 172.6 12.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.19 -25.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -116.84 173.94 6.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -77.31 -54.6 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.1 t -53.5 -30.54 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 9.3 m -67.08 -31.08 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.9 tp -77.87 -57.64 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -51.5 -35.96 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -53.3 -63.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -33.21 34.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -63.66 -36.63 84.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -116.37 34.95 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.99 -44.51 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -119.66 -46.68 2.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -58.38 -70.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.9 p -97.92 135.6 39.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 126.85 -93.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.463 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -101.58 138.45 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt 51.85 68.25 3.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 165.09 32.14 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 4.0 t -150.35 159.97 44.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -144.64 72.34 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -35.72 12.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 1.5 m 57.95 41.19 24.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 4.7 m -124.87 95.77 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.486 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.618 0.723 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -34.45 14.64 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.548 ' HB3' HD22 ' A' ' 491' ' ' LEU . 68.9 m-85 -141.07 134.88 30.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -153.3 113.8 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.85 143.14 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -103.9 -27.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -54.61 -40.49 68.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -126.57 -38.16 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.32 12.98 4.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 157.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.13 145.59 51.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.29 175.8 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 50.2 mt -116.61 -25.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -116.31 167.93 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -72.21 -55.75 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -32.58 55.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.0 m -64.67 -27.18 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -81.62 -54.8 5.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.7 mt -52.0 -37.45 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -51.93 -33.96 39.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.01 -34.77 78.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -117.93 35.53 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.57 -46.13 2.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -118.7 -43.09 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.855 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 5.1 mttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -34.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.564 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -143.04 132.41 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -151.91 118.02 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.92 143.07 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.2 -27.11 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.83 -37.54 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.41 -39.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.82 13.2 4.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 157.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 143.58 51.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -146.63 171.73 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.1 mt -114.41 -24.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -114.6 170.87 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -78.51 -49.02 14.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -35.68 76.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.1 t -62.15 -26.65 68.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.6 tp -78.67 -54.97 5.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 76.6 mt -51.97 -36.01 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -51.93 -64.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -36.09 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.67 -37.02 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -113.0 33.12 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.27 -65.68 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -96.49 -45.29 6.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.89 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.514 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 29.8 mttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.607 0.717 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -32.87 17.77 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.338 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -137.7 127.2 24.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -150.19 118.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.8 t -51.89 142.25 15.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.88 -27.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -57.75 -27.64 63.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.4 p -136.76 -41.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.11 13.48 4.0 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 156.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.514 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.58 144.44 51.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.88 -178.56 6.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.0 mt -118.93 -31.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -113.68 168.78 9.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -73.41 -54.51 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -31.97 48.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.144 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.1 m -65.46 -34.37 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.67 -53.18 11.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.71 -37.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -51.83 -63.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.96 -32.4 33.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.72 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -113.99 35.26 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.74 -63.36 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.99 -45.12 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.905 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.547 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 19.0 mttp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.577 0.703 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -33.1 16.97 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.439 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.7 m-85 -138.38 128.42 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.5 118.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 31.4 t -51.9 142.55 15.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.25 -27.06 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.05 -25.64 61.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.04 -41.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.07 13.89 3.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.92 156.46 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.547 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -126.89 144.65 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.2 179.48 7.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.45 -30.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.56 171.35 7.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -75.2 -52.65 10.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.6 t -55.59 -29.5 59.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.83 -29.05 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -79.51 -53.66 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 70.1 mt -51.71 -37.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -52.25 -63.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -52.16 -32.49 36.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.58 -37.92 89.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -114.47 35.57 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.04 -62.44 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -100.87 -43.79 5.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.474 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 26.9 mttp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.561 0.696 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -33.01 17.77 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.755 2.303 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.423 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.1 m-85 -136.79 125.14 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.01 118.21 6.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.8 142.77 14.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.1 -27.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -56.91 -33.84 67.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -131.16 -39.92 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.81 13.13 4.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -51.79 156.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.474 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.55 145.54 51.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -147.83 -175.58 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 56.8 mt -121.18 -34.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -108.49 179.83 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -84.0 -55.37 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -31.63 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.4 p -65.64 -41.33 92.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -67.07 -54.35 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.72 -38.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -51.83 -62.37 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -52.6 -30.83 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -66.14 -37.16 85.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -115.36 35.91 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.33 -60.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -102.73 -45.36 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.835 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.532 0.682 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -33.13 17.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.383 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.443 ' HB3' HD22 ' A' ' 491' ' ' LEU . 64.4 m-85 -143.12 132.91 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.67 115.58 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.2 t -51.93 143.09 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.8 pt -103.25 -27.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -54.21 -41.39 68.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.84 -37.9 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.45 13.09 4.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -51.69 157.25 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 141.25 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.83 169.21 18.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 55.8 mt -111.19 -24.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -116.26 176.19 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.42 -56.27 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.71 -34.23 51.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 48.2 m -63.74 -31.69 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.1 tp -74.76 -54.35 7.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 62.7 mt -51.68 -37.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -52.01 -64.27 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -51.51 -39.33 57.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -57.79 -33.91 69.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -117.94 35.22 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.73 -56.04 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.28 -22.67 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.784 ' HE3' ' HB1' ' A' ' 484' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.595 0.712 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.71 17.99 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -130.43 126.83 37.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -151.81 117.71 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 38.2 t -51.93 143.85 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.72 -27.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.07 -31.86 65.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -133.49 -40.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.37 13.22 3.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -51.76 157.68 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.784 ' HB1' ' HE3' ' A' ' 474' ' ' LYS . . . -129.46 143.64 50.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -146.47 175.53 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.7 -24.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 170.81 8.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -79.28 -43.0 24.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.5 p -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 2.8 t -71.28 -27.1 63.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.12 -55.31 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 68.9 mt -51.55 -37.54 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -51.92 -63.51 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.87 -34.15 39.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.65 -37.48 87.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -112.02 34.37 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.87 -66.37 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -95.69 -48.45 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.538 0.685 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.82 17.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.517 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.8 m-85 -144.03 131.25 20.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.5 116.76 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.7 t -51.91 143.63 13.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.9 pt -104.03 -27.58 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -54.77 -38.99 67.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -127.92 -38.58 1.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.61 13.16 4.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -51.85 157.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.05 51.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -147.77 173.22 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.72 -24.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.04 176.17 5.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.99 -54.13 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.93 -25.63 44.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.7 m -72.67 -26.71 61.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.5 tp -80.72 -54.1 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.3 mt -51.72 -38.12 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -51.72 -63.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -51.77 -37.19 50.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.13 -36.26 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -116.12 36.96 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.38 -62.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -97.96 -25.98 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.542 0.687 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.67 18.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -137.04 126.2 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -145.09 116.46 8.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.4 t -51.92 143.06 14.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.6 pt -103.23 -27.33 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.71 -38.6 67.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.6 p -128.36 -38.54 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.86 13.23 4.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -51.91 157.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.79 144.62 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.31 176.26 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.25 -24.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -118.56 174.28 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.43 -53.58 6.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.89 -26.23 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.9 m -72.5 -26.96 61.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.1 tp -81.21 -53.24 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.957 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.4 mt -51.75 -38.52 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -51.75 -63.35 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -51.83 -37.02 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.09 -34.63 73.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 -117.62 36.52 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -127.22 -57.37 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.41 -25.26 12.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.875 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 23.0 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -32.65 18.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.479 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.6 m-85 -144.36 129.26 18.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.22 117.22 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 20.9 t -52.26 142.52 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -102.91 -27.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -53.89 -39.94 66.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.9 p -127.14 -38.15 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.53 13.37 4.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -52.28 157.04 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.04 142.83 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.99 170.58 16.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.84 -24.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -114.29 174.75 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.57 -38.25 18.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 6.9 p -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.8 t -74.43 -26.84 60.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -77.25 -55.73 5.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.8 mt -51.62 -38.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.198 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -52.15 -63.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -51.7 -36.4 46.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.29 -35.18 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -117.34 35.22 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -126.57 -58.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.89 -25.64 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.511 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 25.6 mttp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.606 0.717 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -33.03 17.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.433 ' HB3' HD22 ' A' ' 491' ' ' LEU . 67.4 m-85 -137.05 127.69 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -149.98 118.72 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.87 143.12 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.3 -27.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -56.59 -32.72 65.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -132.32 -40.13 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.98 13.26 4.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -51.89 156.68 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.511 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.14 143.83 51.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -146.46 -177.83 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.79 -32.46 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -111.69 173.85 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -77.17 -54.74 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.8 t -54.25 -30.12 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.4 m -67.51 -29.91 69.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.9 tp -79.34 -53.54 6.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.98 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.3 mt -51.73 -38.02 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -51.87 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -51.87 -31.88 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.835 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.66 -36.96 85.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -115.04 36.39 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.18 -62.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.54 -45.51 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.851 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.504 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 35.8 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.571 0.701 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -33.04 17.19 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.477 ' HB3' HD22 ' A' ' 491' ' ' LEU . 56.4 m-85 -138.26 128.44 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.19 118.29 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.9 t -51.88 140.52 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 6.9 pt -101.47 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.91 -30.22 63.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.41 -40.48 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.96 14.17 3.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.448 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.62 156.14 2.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.504 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.37 144.05 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.0 -179.21 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.47 -30.85 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -113.66 173.95 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -77.42 -55.37 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.4 t -53.22 -29.94 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.176 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.4 m -67.73 -32.6 73.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.3 tp -76.01 -53.7 7.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.1 mt -52.42 -37.25 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -51.96 -64.22 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -51.94 -30.63 25.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -67.8 -36.68 80.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -115.9 38.74 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.99 -51.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.73 -47.15 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.548 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 24.5 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.565 0.698 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.73 17.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.406 ' HB3' HD22 ' A' ' 491' ' ' LEU . 54.9 m-85 -135.91 127.14 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -150.2 119.15 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 37.5 t -51.95 142.74 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.11 -27.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -57.35 -28.27 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.71 -40.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.36 13.43 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 156.01 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.548 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.65 143.32 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -145.23 -175.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 65.3 mt -119.68 -35.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -109.77 -179.59 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.87 -54.81 4.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.8 p -51.82 -30.69 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.4 p -67.09 -39.46 86.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 476' ' ' TYR . 17.0 tp -69.18 -45.95 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.97 -38.45 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -61.89 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -53.35 -30.41 39.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -67.42 -35.95 80.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -115.11 33.73 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.94 -61.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -100.95 -45.11 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.57 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 41.6 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.86 17.73 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.332 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.407 ' HB3' HD22 ' A' ' 491' ' ' LEU . 65.6 m-85 -137.61 125.45 22.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -147.58 119.28 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 47.5 t -51.89 145.04 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -104.44 -27.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.18 -34.57 66.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.0 p -131.47 -39.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.95 13.98 3.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 156.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.57 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.2 144.81 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.15 -178.06 6.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.44 -31.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.35 -177.38 3.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.73 -52.72 5.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -25.91 59.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -72.81 -28.23 62.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 476' ' ' TYR . 15.3 tp -79.38 -51.71 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.7 mt -51.66 -38.11 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -51.89 -61.14 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -54.77 -26.81 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.25 -31.19 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -118.41 31.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -119.34 -52.62 2.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.48 -48.38 2.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.554 0.692 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -33.0 17.39 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.31 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.41 ' HB3' HD22 ' A' ' 491' ' ' LEU . 57.1 m-85 -137.75 129.06 27.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -151.65 118.12 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 34.1 t -51.93 142.65 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.25 -27.22 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.03 -24.53 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -140.15 -41.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.01 3.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 156.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.334 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.21 142.33 51.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.126 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -145.15 -179.12 6.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.42 -34.58 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -109.41 175.96 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.43 -51.32 9.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -33.46 65.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -32.89 74.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.9 tp -75.69 -54.22 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 78.4 mt -51.7 -37.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -52.09 -63.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -51.97 -32.68 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -65.14 -36.08 83.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -116.03 35.58 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.98 -47.4 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -117.72 -46.81 2.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.519 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 28.9 mttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.571 0.7 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.67 18.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.375 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.483 ' HB3' HD22 ' A' ' 491' ' ' LEU . 59.4 m-85 -139.14 128.36 24.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.97 118.81 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.8 t -52.07 141.29 18.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.96 -26.98 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -56.8 -32.1 65.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.4 p -132.69 -40.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.78 14.07 3.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 156.31 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.727 0.298 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.34 144.72 51.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -147.12 179.67 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.87 -31.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -113.2 175.43 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.56 -53.73 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.4 t -54.51 -29.31 50.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.9 -29.95 68.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.8 tp -79.21 -54.61 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.57 -37.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -52.03 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -52.54 -29.38 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -70.22 -35.49 73.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -115.86 39.85 2.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -127.54 -54.09 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -112.98 -47.14 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.929 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.495 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 30.4 mttt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.579 0.704 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -32.65 18.27 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 491' ' ' LEU . 74.7 m-85 -139.03 127.28 22.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.972 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -148.2 116.93 6.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 17.4 t -52.11 139.94 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.72 -27.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.0 -37.99 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.2 p -128.51 -38.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.03 13.21 4.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -52.87 157.12 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.97 143.79 50.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -146.42 -178.76 6.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.4 mt -119.21 -31.24 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -112.97 161.55 16.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -67.12 -55.32 14.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.7 t -53.45 -30.85 42.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 47.1 m -67.05 -30.98 71.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.0 tp -76.83 -53.68 7.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.47 -37.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -51.56 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -51.78 -35.28 43.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -61.32 -35.62 77.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -115.76 32.48 6.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.22 -65.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -95.12 -25.56 16.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 179.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.0 mptt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.605 0.716 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.89 124.25 21.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.23 118.42 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.5 t -52.03 142.87 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -103.37 -27.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -57.56 -28.01 63.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -136.59 -40.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.89 13.84 3.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 156.19 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.1 146.15 50.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -148.1 -177.3 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.78 -33.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -112.85 175.96 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -78.61 -53.5 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.6 t -54.91 -26.59 37.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -71.89 -30.01 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.48 -53.97 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.65 -37.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -51.8 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -52.93 -29.44 28.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -68.99 -36.34 77.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -113.45 32.86 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.33 -64.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -96.05 -50.55 4.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.849 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 14.8 mttm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.557 0.694 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.84 17.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.431 ' HB3' HD22 ' A' ' 491' ' ' LEU . 60.3 m-85 -143.9 130.99 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -151.63 115.38 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 19.5 t -51.88 140.19 20.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.26 -27.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -54.66 -34.82 62.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.71 -39.66 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.69 12.94 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.51 156.07 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.54 140.75 52.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -143.17 173.98 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.26 -25.09 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.09 170.81 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -76.35 -54.7 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.3 p -55.9 -25.37 42.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.7 t -72.37 -28.2 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.8 tp -80.05 -54.82 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.61 -35.14 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -53.92 -64.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -52.13 -34.96 46.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.36 -33.38 74.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -118.71 32.38 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.88 -47.4 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -116.6 -26.18 7.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.728 ' HD2' ' HB1' ' A' ' 484' ' ' ALA . 10.1 mttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.522 0.677 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.07 17.42 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.526 ' HB3' HD22 ' A' ' 491' ' ' LEU . 62.5 m-85 -141.39 130.91 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -151.69 117.68 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.56 142.85 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.54 -27.35 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -57.84 -23.62 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -141.26 -41.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.45 3.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.505 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.47 156.44 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 474' ' ' LYS . . . -127.47 142.07 51.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -144.79 172.6 12.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.19 -25.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -116.84 173.94 6.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -77.31 -54.6 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.1 t -53.5 -30.54 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 9.3 m -67.08 -31.08 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.9 tp -77.87 -57.64 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -51.5 -35.96 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -53.3 -63.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -33.21 34.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -63.66 -36.63 84.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -116.37 34.95 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.99 -44.51 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -119.66 -46.68 2.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 23.3 p -174.4 145.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 110.811 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.5 m -165.09 144.24 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 176.96 -157.23 22.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 5.5 m -147.17 120.08 8.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 41.1 t -92.37 112.61 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.11 28.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 12.1 t -171.7 142.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -69.32 137.49 29.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.482 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.75 160.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -139.67 160.69 60.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.618 0.723 . . . . 0.0 110.823 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -34.45 14.64 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.548 ' HB3' HD22 ' A' ' 491' ' ' LEU . 68.9 m-85 -141.07 134.88 30.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -153.3 113.8 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.85 143.14 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -103.9 -27.41 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -54.61 -40.49 68.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -126.57 -38.16 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.32 12.98 4.5 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 157.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -129.13 145.59 51.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.29 175.8 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 50.2 mt -116.61 -25.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -116.31 167.93 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -72.21 -55.75 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -32.58 55.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.0 m -64.67 -27.18 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -81.62 -54.8 5.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.7 mt -52.0 -37.45 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -51.93 -33.96 39.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.831 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.01 -34.77 78.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -117.93 35.53 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.57 -46.13 2.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -118.7 -43.09 2.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -61.46 -72.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.3 p -96.07 25.6 4.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -103.63 -131.14 7.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -79.59 147.69 31.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 52.55 73.31 0.97 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.555 0.693 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.16 17.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.273 . . . . 0.0 112.288 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 39.6 t -108.77 98.91 8.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -163.49 -73.64 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 140.8 43.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 8.5 p -119.79 28.63 8.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 34.0 p -53.92 163.83 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.883 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 CA-C-O 119.125 -0.82 . . . . 0.0 112.515 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 30.4 p -121.47 163.03 19.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 m -136.02 138.57 42.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -70.74 132.69 22.44 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 30.5 t -96.71 -35.86 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.814 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 43.0 t -127.3 96.75 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -138.86 97.2 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 6.3 t -125.75 125.2 42.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.8 0.333 . . . . 0.0 111.133 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 131.44 173.98 13.52 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -107.11 136.09 47.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -128.62 160.61 61.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -34.35 14.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.564 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -143.04 132.41 23.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -151.91 118.02 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.92 143.07 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.2 -27.11 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.83 -37.54 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.41 -39.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.82 13.2 4.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 157.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 143.58 51.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -146.63 171.73 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.1 mt -114.41 -24.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -114.6 170.87 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -78.51 -49.02 14.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -35.68 76.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.1 t -62.15 -26.65 68.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.6 tp -78.67 -54.97 5.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 76.6 mt -51.97 -36.01 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -51.93 -64.26 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -36.09 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . 0.482 ' O ' HG22 ' A' ' 500' ' ' THR . 1.1 t-105 -62.67 -37.02 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -113.0 33.12 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.27 -65.68 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -96.49 -45.29 6.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -60.11 -70.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 495' ' ' TRP . 15.1 t -129.38 172.3 11.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -167.21 176.16 42.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.491 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -114.91 34.87 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -147.28 73.43 11.91 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -27.15 26.58 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.278 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 1.8 p -76.64 81.42 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -175.19 170.27 43.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -16.87 37.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 77.1 p -84.88 123.21 30.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.4 m -85.65 -31.15 22.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.467 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 60.8 p -161.19 117.8 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 38.9 m -114.43 173.83 6.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 144.38 110.3 0.7 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.456 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 10.5 t -167.53 154.73 8.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 37.5 m -145.05 169.4 18.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -153.53 91.7 0.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 9.9 t -88.68 -28.97 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -83.13 150.97 28.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -122.32 154.05 38.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.514 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 29.8 mttt -113.16 160.65 30.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.717 . . . . 0.0 110.857 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -32.87 17.77 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.699 2.266 . . . . 0.0 112.338 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -137.7 127.2 24.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -150.19 118.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.8 t -51.89 142.25 15.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.88 -27.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -57.75 -27.64 63.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.4 p -136.76 -41.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.11 13.48 4.0 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 156.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.514 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.58 144.44 51.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.88 -178.56 6.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.0 mt -118.93 -31.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -113.68 168.78 9.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -73.41 -54.51 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -31.97 48.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.144 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 16.1 m -65.46 -34.37 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.67 -53.18 11.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.71 -37.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -51.83 -63.27 1.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.96 -32.4 33.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.72 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -113.99 35.26 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.74 -63.36 1.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.99 -45.12 5.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -57.65 -67.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.905 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.2 p -106.28 160.49 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 131.83 -179.16 17.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.55 39.42 2.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 110.896 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 160.32 69.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 80.42 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.721 2.281 . . . . 0.0 112.311 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 27.2 p -53.13 -58.33 7.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 171.41 -73.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 176.8 6.27 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.712 2.275 . . . . 0.0 112.38 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 58.4 m -62.38 144.59 55.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.835 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 23.0 m -136.54 126.9 26.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.485 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 34.9 p -60.76 140.65 57.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.1 t -133.2 -51.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 172.37 -30.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 53.0 m -65.69 113.51 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.884 0.373 . . . . 0.0 110.82 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 66.4 p -105.5 172.64 6.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.81 92.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.1 p -65.33 174.44 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.352 . . . . 0.0 111.115 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 74.81 135.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -158.55 126.94 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.547 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 19.0 mttp -130.05 160.7 64.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.577 0.703 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -33.1 16.97 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.439 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.7 m-85 -138.38 128.42 25.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.94 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.5 118.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 31.4 t -51.9 142.55 15.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.25 -27.06 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.05 -25.64 61.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.04 -41.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.07 13.89 3.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.92 156.46 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.547 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -126.89 144.65 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.2 179.48 7.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 76.5 mt -117.45 -30.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.56 171.35 7.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -75.2 -52.65 10.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.6 t -55.59 -29.5 59.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.83 -29.05 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -79.51 -53.66 6.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 70.1 mt -51.71 -37.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -52.25 -63.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -52.16 -32.49 36.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -64.58 -37.92 89.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -114.47 35.57 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.04 -62.44 1.34 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -100.87 -43.79 5.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.41 -66.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.3 p -108.83 139.7 43.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 164.87 -117.01 0.73 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -87.8 81.99 7.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp 63.05 160.64 0.12 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -16.41 37.29 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.674 2.249 . . . . 0.0 112.367 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 1.5 t 52.91 55.61 8.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 165.09 67.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.467 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 130.82 19.9 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.682 2.254 . . . . 0.0 112.339 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 32.8 t -157.14 164.9 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 11.6 t -124.42 42.58 3.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.82 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.49 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 31.1 t -165.08 128.17 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 36.6 p -94.72 -176.53 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.39 147.45 18.22 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 14.9 m -139.61 154.13 47.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.825 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 3.0 p -140.05 137.88 34.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.853 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.77 -142.83 4.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 23.6 p -111.66 123.36 50.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.166 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -105.93 99.41 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -103.1 56.88 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.474 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 26.9 mttp -117.26 160.62 36.8 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.561 0.696 . . . . 0.0 110.939 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -33.01 17.77 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.755 2.303 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.423 ' HB3' HD22 ' A' ' 491' ' ' LEU . 66.1 m-85 -136.79 125.14 23.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -149.01 118.21 6.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.8 142.77 14.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.1 -27.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -56.91 -33.84 67.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -131.16 -39.92 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.81 13.13 4.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -51.79 156.95 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.474 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.55 145.54 51.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -147.83 -175.58 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 56.8 mt -121.18 -34.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -108.49 179.83 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -84.0 -55.37 4.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -31.63 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 15.4 p -65.64 -41.33 92.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.2 tp -67.07 -54.35 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.2 mt -51.72 -38.33 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -51.83 -62.37 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -52.6 -30.83 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -66.14 -37.16 85.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -115.36 35.91 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.33 -60.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -102.73 -45.36 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -57.46 -68.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.8 p -103.83 38.47 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -133.91 -60.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.513 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.07 128.03 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -101.56 160.7 25.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.544 0.687 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.42 0.9 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 20.3 m -115.39 -30.22 6.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -92.14 -175.83 42.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 130.94 20.29 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.389 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 5.4 t -132.64 116.22 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 48.1 t -115.33 124.83 52.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.508 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 58.1 m -91.17 -60.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.811 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 1.4 t -87.68 128.57 35.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -86.4 -168.07 44.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 40.7 t -165.16 148.45 8.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 0.0 110.849 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 46.0 p -106.07 120.09 40.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.55 124.81 3.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.502 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 43.0 p -115.66 123.68 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.71 151.09 26.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.23 156.4 31.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.911 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -128.1 160.57 61.01 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.532 0.682 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -33.13 17.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.383 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.443 ' HB3' HD22 ' A' ' 491' ' ' LEU . 64.4 m-85 -143.12 132.91 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.67 115.58 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.2 t -51.93 143.09 14.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.8 pt -103.25 -27.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -54.21 -41.39 68.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.84 -37.9 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.45 13.09 4.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -51.69 157.25 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.51 141.25 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.83 169.21 18.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 55.8 mt -111.19 -24.37 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -116.26 176.19 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.42 -56.27 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.71 -34.23 51.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 48.2 m -63.74 -31.69 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.1 tp -74.76 -54.35 7.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 62.7 mt -51.68 -37.26 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -52.01 -64.27 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -51.51 -39.33 57.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -57.79 -33.91 69.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -117.94 35.22 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.73 -56.04 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.933 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.28 -22.67 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -90.14 -62.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 10.2 p -120.06 -172.45 2.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.107 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 95.4 -120.39 6.5 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.451 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -58.23 98.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -130.37 72.39 81.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.625 0.726 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.73 4.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 26.2 p -107.45 96.41 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -66.63 -72.2 0.8 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 103.42 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 1.7 t -70.58 108.23 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.9 t -83.8 93.5 7.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.496 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 16.2 t -169.1 132.31 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.872 0.367 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.3 t -159.78 160.93 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -178.44 39.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 3.7 m -123.01 167.58 13.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 95.7 p -59.92 114.97 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 158.74 -67.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 4.0 t -62.04 155.16 24.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -153.71 -98.33 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.49 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -168.88 166.5 11.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.784 ' HE3' ' HB1' ' A' ' 484' ' ' ALA . 0.0 OUTLIER -108.03 160.68 26.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.863 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.71 17.99 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -130.43 126.83 37.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -151.81 117.71 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 38.2 t -51.93 143.85 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.72 -27.15 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.07 -31.86 65.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -133.49 -40.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.37 13.22 3.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -51.76 157.68 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.784 ' HB1' ' HE3' ' A' ' 474' ' ' LYS . . . -129.46 143.64 50.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.105 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -146.47 175.53 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.7 -24.71 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 170.81 8.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -79.28 -43.0 24.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.5 p -63.71 -29.14 70.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.074 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 2.8 t -71.28 -27.1 63.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.12 -55.31 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 68.9 mt -51.55 -37.54 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -51.92 -63.51 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.87 -34.15 39.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . 0.426 ' O ' HG22 ' A' ' 500' ' ' THR . 1.2 t-105 -64.65 -37.48 87.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -112.02 34.37 4.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -122.87 -66.37 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -95.69 -48.45 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -56.54 -72.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 495' ' ' TRP . 9.2 t -126.3 164.1 21.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.177 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -177.49 -164.66 31.37 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.463 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -114.21 35.57 4.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -127.92 160.66 60.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.557 0.694 . . . . 0.0 110.879 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 89.52 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.705 2.27 . . . . 0.0 112.318 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 9.3 p -107.79 -43.94 4.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 138.14 -167.22 25.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 126.51 13.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.358 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 36.3 p -124.74 71.74 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 4.2 m -100.5 145.53 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.848 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.501 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.1 m -140.91 133.61 28.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.898 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 52.7 p -114.67 131.53 56.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 178.78 116.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 4.6 m -131.2 130.84 43.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.823 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 97.0 p -84.84 174.93 9.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.815 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 101.18 67.33 0.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 13.1 m -116.88 74.47 0.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.131 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -170.83 115.34 0.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -81.14 129.21 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -129.84 159.1 71.53 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.82 17.83 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.517 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.8 m-85 -144.03 131.25 20.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.5 116.76 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.7 t -51.91 143.63 13.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.9 pt -104.03 -27.58 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -54.77 -38.99 67.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.1 p -127.92 -38.58 1.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.61 13.16 4.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -51.85 157.18 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.27 145.05 51.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -147.77 173.22 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.72 -24.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.04 176.17 5.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -81.99 -54.13 5.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.93 -25.63 44.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.152 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 26.7 m -72.67 -26.71 61.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.5 tp -80.72 -54.1 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.3 mt -51.72 -38.12 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -51.72 -63.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -51.77 -37.19 50.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.13 -36.26 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -116.12 36.96 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.38 -62.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -97.96 -25.98 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -83.65 -64.95 1.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 12.2 p -116.2 123.19 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.156 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 164.45 -146.87 11.85 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.63 133.15 35.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 110.874 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.21 73.69 0.83 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.562 0.696 . . . . 0.0 110.86 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 124.99 11.64 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.644 2.23 . . . . 0.0 112.372 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 37.4 t -127.86 150.38 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 174.93 167.15 33.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 93.96 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.353 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 12.7 t -69.47 -37.92 77.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.18 126.52 35.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.519 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 45.3 t -124.99 105.56 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 42.1 m -71.41 122.7 20.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -176.44 -101.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 5.1 t -109.88 29.73 7.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.874 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 85.4 p -139.75 -178.49 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 156.04 -84.25 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 8.9 t -137.52 142.63 41.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.135 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -68.79 -115.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.73 31.08 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -131.78 160.75 66.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.542 0.687 . . . . 0.0 110.922 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.67 18.05 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' A' ' 491' ' ' LEU . 50.8 m-85 -137.04 126.2 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -145.09 116.46 8.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.4 t -51.92 143.06 14.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.6 pt -103.23 -27.33 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.71 -38.6 67.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.6 p -128.36 -38.54 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.86 13.23 4.18 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -51.91 157.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.79 144.62 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -147.31 176.26 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.25 -24.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -118.56 174.28 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.43 -53.58 6.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.89 -26.23 46.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.9 m -72.5 -26.96 61.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.1 tp -81.21 -53.24 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.957 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 80.4 mt -51.75 -38.52 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 34.6 mtt85 -51.75 -63.35 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -51.83 -37.02 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.09 -34.63 73.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 42.8 mtp85 -117.62 36.52 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -127.22 -57.37 1.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.41 -25.26 12.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -84.04 -63.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 11.9 p -116.35 -172.63 2.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 107.08 101.2 2.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 54.53 36.61 26.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -114.45 160.06 34.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.575 0.702 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 163.6 37.68 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.371 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 46.9 m -157.54 127.85 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 174.87 69.05 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 168.77 20.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.636 2.224 . . . . 0.0 112.318 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 21.7 t -104.48 151.3 23.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 59.6 p -171.43 156.38 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.476 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.5 t -159.37 145.25 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 48.9 p -166.95 124.51 1.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.838 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 173.03 119.97 0.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 1.8 p -105.54 137.96 42.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 110.86 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 4.2 p -92.88 53.76 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 143.07 149.13 5.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.455 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 40.0 p -146.39 115.53 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.348 . . . . 0.0 111.129 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -108.23 -159.1 19.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.2 -178.0 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -156.34 160.65 30.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -32.65 18.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.479 ' HB3' HD22 ' A' ' 491' ' ' LEU . 53.6 m-85 -144.36 129.26 18.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -149.22 117.22 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 20.9 t -52.26 142.52 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.5 pt -102.91 -27.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -53.89 -39.94 66.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.9 p -127.14 -38.15 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.53 13.37 4.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -52.28 157.04 1.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -128.04 142.83 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.125 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.99 170.58 16.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.84 -24.66 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -114.29 174.75 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.57 -38.25 18.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 6.9 p -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.8 t -74.43 -26.84 60.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.2 tp -77.25 -55.73 5.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.8 mt -51.62 -38.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.198 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -52.15 -63.66 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -51.7 -36.4 46.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.29 -35.18 74.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -117.34 35.22 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -126.57 -58.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.89 -25.64 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -84.27 -69.41 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 11.9 p -109.37 37.31 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -125.93 20.93 6.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -163.09 128.52 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -52.37 160.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 120.24 7.05 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 4.4 m -108.1 156.32 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -55.75 -73.47 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 129.16 17.2 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 0.0 112.376 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 2.2 m -169.65 168.82 8.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 3.4 m -81.52 -55.38 4.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.448 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 79.7 p -171.4 129.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.884 0.373 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 50.3 m -111.37 170.35 8.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -108.05 41.74 2.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.0 m -74.05 118.54 17.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 3.3 p -138.94 152.6 47.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -132.12 146.42 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.518 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.7 m -89.43 122.94 33.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.115 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 105.26 167.23 23.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 175.09 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.511 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 25.6 mttp -144.01 160.68 48.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.606 0.717 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -33.03 17.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.433 ' HB3' HD22 ' A' ' 491' ' ' LEU . 67.4 m-85 -137.05 127.69 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -149.98 118.72 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 36.2 t -51.87 143.12 13.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.3 -27.44 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -56.59 -32.72 65.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -132.32 -40.13 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.98 13.26 4.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -51.89 156.68 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.511 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.14 143.83 51.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -146.46 -177.83 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.79 -32.46 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -111.69 173.85 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -77.17 -54.74 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.8 t -54.25 -30.12 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 42.4 m -67.51 -29.91 69.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.9 tp -79.34 -53.54 6.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.98 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.3 mt -51.73 -38.02 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -51.87 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -51.87 -31.88 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.835 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.66 -36.96 85.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -115.04 36.39 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.18 -62.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.94 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.54 -45.51 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -57.52 -65.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 18.2 p -109.5 161.94 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 130.09 -103.36 0.57 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.484 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -120.45 142.97 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm 51.84 68.15 3.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.567 0.699 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 97.67 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.715 2.276 . . . . 0.0 112.328 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.84 165.06 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 167.82 73.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -19.71 36.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.255 . . . . 0.0 112.391 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 36.0 p -80.44 174.92 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 63.0 p -130.67 102.77 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.15 -0.805 . . . . 0.0 112.485 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 97.9 p -137.09 161.59 35.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 8.2 t -126.55 131.87 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -90.12 160.62 28.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 15.3 t -165.8 132.19 2.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 2.8 p -151.75 165.29 34.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 155.06 97.27 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 1.3 p -126.58 122.53 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.12 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -172.37 139.76 5.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.523 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -89.04 90.07 8.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.504 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 35.8 mttt -102.11 160.66 25.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.701 . . . . 0.0 110.914 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -33.04 17.19 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.704 2.269 . . . . 0.0 112.354 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.477 ' HB3' HD22 ' A' ' 491' ' ' LEU . 56.4 m-85 -138.26 128.44 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.19 118.29 5.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.9 t -51.88 140.52 19.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 6.9 pt -101.47 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.91 -30.22 63.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.41 -40.48 0.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.96 14.17 3.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.448 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.62 156.14 2.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.504 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.37 144.05 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -146.0 -179.21 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.47 -30.85 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -113.66 173.95 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -77.42 -55.37 5.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.4 t -53.22 -29.94 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.176 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.4 m -67.73 -32.6 73.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.3 tp -76.01 -53.7 7.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.1 mt -52.42 -37.25 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -51.96 -64.22 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -51.94 -30.63 25.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . 0.578 ' O ' HG23 ' A' ' 500' ' ' THR . 1.1 t-105 -67.8 -36.68 80.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -115.9 38.74 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -125.99 -51.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.73 -47.15 2.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -51.62 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 495' ' ' TRP . 36.7 p -60.01 177.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 53.76 -149.06 15.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -71.68 139.13 49.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -69.36 160.55 78.63 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.591 0.71 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -20.36 35.07 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.633 2.222 . . . . 0.0 112.4 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 8.4 t -168.52 177.77 5.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.28 19.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 90.12 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.682 2.255 . . . . 0.0 112.333 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 42.8 m -105.27 134.55 48.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 84.1 p -60.38 -28.68 68.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.484 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.6 t 52.11 33.9 13.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 35.9 m -121.22 167.52 12.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 56.6 79.0 0.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.456 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 79.6 p -142.95 143.24 31.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 5.6 m -134.57 167.05 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -155.19 -75.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 8.8 t -114.38 142.29 46.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.149 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -92.99 -131.07 5.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.9 -37.56 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.351 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.548 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 24.5 mttt -60.57 160.71 17.38 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.565 0.698 . . . . 0.0 110.908 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.73 17.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.354 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.406 ' HB3' HD22 ' A' ' 491' ' ' LEU . 54.9 m-85 -135.91 127.14 28.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -150.2 119.15 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 37.5 t -51.95 142.74 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -103.11 -27.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -57.35 -28.27 62.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.71 -40.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.36 13.43 3.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 156.01 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.548 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.65 143.32 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -145.23 -175.38 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 65.3 mt -119.68 -35.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -109.77 -179.59 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.87 -54.81 4.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.8 p -51.82 -30.69 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 29.4 p -67.09 -39.46 86.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 476' ' ' TYR . 17.0 tp -69.18 -45.95 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.97 -38.45 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -61.89 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -53.35 -30.41 39.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -67.42 -35.95 80.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -115.11 33.73 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -121.94 -61.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -100.95 -45.11 5.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -59.29 -74.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 14.7 t -126.4 172.42 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 176.33 -73.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -136.05 132.99 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.937 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp 51.88 68.16 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.588 0.709 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -30.14 22.73 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 0.0 112.321 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 3.0 p -59.46 167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -151.71 176.79 29.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -27.69 26.22 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 50.6 m -85.9 162.96 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 22.9 t -132.55 34.12 3.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.508 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 39.3 m -119.13 159.07 24.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.351 . . . . 0.0 110.889 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.6 t -119.29 149.08 42.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 139.09 122.88 2.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.4 m -126.76 85.74 2.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 1.3 t -111.73 155.23 23.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 148.74 -103.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.453 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 17.4 p -52.18 122.9 9.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.813 0.34 . . . . 0.0 111.162 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.58 -179.48 40.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.71 175.46 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.57 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 41.6 mttt -137.69 160.7 63.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.86 17.73 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.332 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.407 ' HB3' HD22 ' A' ' 491' ' ' LEU . 65.6 m-85 -137.61 125.45 22.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -147.58 119.28 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 47.5 t -51.89 145.04 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -104.44 -27.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -56.18 -34.57 66.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.0 p -131.47 -39.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.95 13.98 3.92 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 156.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.57 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.2 144.81 50.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -147.15 -178.06 6.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.44 -31.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.185 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -112.35 -177.38 3.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.73 -52.72 5.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -25.91 59.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -72.81 -28.23 62.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' A' ' 476' ' ' TYR . 15.3 tp -79.38 -51.71 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 77.7 mt -51.66 -38.11 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -51.89 -61.14 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -54.77 -26.81 36.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -73.25 -31.19 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -118.41 31.9 6.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -119.34 -52.62 2.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -113.48 -48.38 2.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -53.94 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 13.4 p -108.87 24.22 13.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -105.29 178.27 23.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.76 157.73 37.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -147.8 160.68 37.55 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -37.53 9.05 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.318 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 12.7 p -77.81 145.93 36.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -129.4 178.68 17.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 107.7 1.92 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.676 2.251 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 30.8 p -131.58 161.44 32.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.8 p -52.36 -48.65 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.493 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 87.6 p -69.39 167.51 16.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.344 . . . . 0.0 110.886 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.9 t -170.38 169.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -155.63 -173.82 24.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.6 m -126.86 56.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 1.1 p -105.41 81.76 1.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -71.74 111.48 3.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 9.7 t -78.3 155.58 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 138.67 101.32 0.53 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.489 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -100.94 114.48 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -120.24 159.3 48.1 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -33.0 17.39 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.31 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.41 ' HB3' HD22 ' A' ' 491' ' ' LEU . 57.1 m-85 -137.75 129.06 27.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -151.65 118.12 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 34.1 t -51.93 142.65 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.9 pt -103.25 -27.22 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.03 -24.53 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.5 p -140.15 -41.28 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.01 3.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 156.66 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.334 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.21 142.33 51.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.126 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -145.15 -179.12 6.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.42 -34.58 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -109.41 175.96 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.43 -51.32 9.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -33.46 65.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -32.89 74.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 476' ' ' TYR . 11.9 tp -75.69 -54.22 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 78.4 mt -51.7 -37.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -52.09 -63.62 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -51.97 -32.68 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -65.14 -36.08 83.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -116.03 35.58 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.98 -47.4 2.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -117.72 -46.81 2.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -57.2 -73.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.6 p -94.4 -33.6 13.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.163 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.85 5.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -84.83 163.13 19.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -101.7 159.29 29.85 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.616 0.722 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 94.92 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.697 2.264 . . . . 0.0 112.383 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 2.8 m -129.27 29.11 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -173.59 179.89 44.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 137.12 34.63 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.656 2.238 . . . . 0.0 112.31 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 7.5 t -125.62 43.46 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 13.7 m -128.9 62.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.836 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.458 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 19.4 t -123.47 70.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.4 t -92.94 163.7 13.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -133.77 76.66 0.39 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 4.3 t -153.52 137.77 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 9.2 m -116.97 122.5 44.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -84.84 -167.8 43.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 5.2 t -172.75 139.35 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 156.65 151.7 6.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -86.37 93.83 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.887 0.375 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.519 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 28.9 mttt -107.6 160.74 25.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.571 0.7 . . . . 0.0 110.939 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.67 18.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.375 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.483 ' HB3' HD22 ' A' ' 491' ' ' LEU . 59.4 m-85 -139.14 128.36 24.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.97 118.81 6.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 23.8 t -52.07 141.29 18.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.96 -26.98 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -56.8 -32.1 65.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.4 p -132.69 -40.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.78 14.07 3.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 156.31 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.727 0.298 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -127.34 144.72 51.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -147.12 179.67 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.87 -31.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -113.2 175.43 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.56 -53.73 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.4 t -54.51 -29.31 50.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.4 t -68.9 -29.95 68.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 476' ' ' TYR . 13.8 tp -79.21 -54.61 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.57 -37.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.144 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -52.03 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -52.54 -29.38 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -70.22 -35.49 73.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -115.86 39.85 2.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -127.54 -54.09 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -112.98 -47.14 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -51.7 -50.09 61.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.5 p -108.58 122.38 46.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 109.52 74.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -83.64 131.04 34.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.393 . . . . 0.0 110.894 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -120.48 160.68 42.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.842 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 96.09 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.372 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 37.9 t -168.62 144.24 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 144.86 73.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -172.2 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.729 2.286 . . . . 0.0 112.339 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 5.8 p -153.74 148.98 26.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 6.9 p -89.45 130.38 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.145 -0.809 . . . . 0.0 112.514 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 46.0 m -128.25 113.45 15.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.361 . . . . 0.0 110.904 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 26.0 p -147.0 112.38 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.821 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -164.89 134.61 3.39 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 6.2 t -171.18 133.18 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.849 0.357 . . . . 0.0 110.883 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 5.0 m -159.55 169.23 24.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 155.05 133.01 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 34.2 p -119.25 78.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.175 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -138.67 131.78 5.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.52 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 157.6 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.495 ' CD ' ' HB1' ' A' ' 484' ' ' ALA . 30.4 mttt -133.48 160.71 67.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.579 0.704 . . . . 0.0 110.875 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -32.65 18.27 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.335 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.451 ' HB3' HD22 ' A' ' 491' ' ' LEU . 74.7 m-85 -139.03 127.28 22.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.972 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -148.2 116.93 6.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 17.4 t -52.11 139.94 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.72 -27.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.0 -37.99 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 9.2 p -128.51 -38.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.03 13.21 4.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -52.87 157.12 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 474' ' ' LYS . . . -128.97 143.79 50.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -146.42 -178.76 6.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.4 mt -119.21 -31.24 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -112.97 161.55 16.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -67.12 -55.32 14.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 9.7 t -53.45 -30.85 42.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 47.1 m -67.05 -30.98 71.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 476' ' ' TYR . 14.0 tp -76.83 -53.68 7.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.47 -37.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -51.56 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -51.78 -35.28 43.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -61.32 -35.62 77.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -115.76 32.48 6.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.22 -65.11 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -95.12 -25.56 16.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -84.85 -71.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.3 p -109.88 122.3 47.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.147 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 131.94 -114.5 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -68.87 109.51 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.9 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -59.9 160.69 14.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.534 0.683 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 111.0 2.69 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 47.8 t -58.55 -48.89 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -74.4 -170.34 23.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.94 15.44 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.719 2.28 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 3.9 t -81.85 161.5 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 6.4 m -122.5 -176.53 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.164 -0.798 . . . . 0.0 112.481 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 12.1 t -113.99 -36.44 4.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 110.825 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.7 m -85.29 151.69 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -149.81 -91.92 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.5 m -98.6 113.21 25.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.347 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 2.7 t -101.26 136.72 40.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 146.18 146.54 4.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 6.1 p -91.82 127.75 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 111.123 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 -145.53 18.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 150.01 26.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.922 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -91.73 160.7 35.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.716 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -32.44 18.55 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.89 124.25 21.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.23 118.42 6.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.5 t -52.03 142.87 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 7.7 pt -103.37 -27.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -57.56 -28.01 63.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -136.59 -40.86 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.89 13.84 3.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 156.19 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -127.1 146.15 50.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -148.1 -177.3 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.78 -33.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -112.85 175.96 5.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -78.61 -53.5 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.6 t -54.91 -26.59 37.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.3 t -71.89 -30.01 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.852 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.48 -53.97 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.65 -37.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -51.8 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -52.93 -29.44 28.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . 0.439 ' O ' HG22 ' A' ' 500' ' ' THR . 1.1 t-105 -68.99 -36.34 77.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -113.45 32.86 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.33 -64.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -96.05 -50.55 4.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -55.13 -74.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 495' ' ' TRP . 9.6 t -124.46 164.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 127.45 -69.33 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -105.77 77.33 1.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.868 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 160.69 0.12 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.543 0.687 . . . . 0.0 110.949 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 128.65 16.33 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.651 2.234 . . . . 0.0 112.373 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.48 132.41 9.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -173.6 172.08 44.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 122.65 9.32 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 25.5 p -164.62 120.21 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 1.3 t -167.86 -176.52 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 34.4 p -132.5 74.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.1 t -128.27 85.04 2.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 164.45 156.94 9.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.443 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 11.1 p -166.3 129.13 1.95 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 30.0 m -76.31 152.56 36.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . -111.58 -160.02 15.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.462 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 2.1 t -174.28 121.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 178.98 174.99 45.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.481 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -98.83 124.43 43.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -132.16 160.74 66.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.557 0.694 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.84 17.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.431 ' HB3' HD22 ' A' ' 491' ' ' LEU . 60.3 m-85 -143.9 130.99 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -151.63 115.38 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 19.5 t -51.88 140.19 20.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.1 pt -101.26 -27.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -54.66 -34.82 62.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.71 -39.66 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 124.69 12.94 3.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.51 156.07 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -126.54 140.75 52.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -143.17 173.98 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.26 -25.09 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -117.09 170.81 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -76.35 -54.7 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.3 p -55.9 -25.37 42.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 1.7 t -72.37 -28.2 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 476' ' ' TYR . 10.8 tp -80.05 -54.82 5.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 79.4 mt -51.61 -35.14 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 22.6 mtt-85 -53.92 -64.23 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -52.13 -34.96 46.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -62.36 -33.38 74.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -118.71 32.38 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -123.88 -47.4 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -116.6 -26.18 7.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -84.74 -69.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.7 p -107.16 33.32 4.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.121 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -127.35 -70.84 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.55 169.75 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.76 160.7 76.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 127.62 14.85 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.703 2.269 . . . . 0.0 112.368 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 38.9 m -123.83 60.37 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.56 70.85 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 79.54 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.344 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 3.8 m -123.74 101.65 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 10.0 t -63.28 -35.68 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.16 -0.8 . . . . 0.0 112.434 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 14.1 m -78.1 96.09 5.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.92 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 54.7 p -114.82 176.41 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -130.31 -61.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.483 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 6.2 p -144.42 166.36 25.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 29.6 t -97.97 -42.17 7.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 173.65 -155.91 23.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' THR . . . . . . . . . . . . . 90.4 m -93.76 107.95 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.176 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.1 174.16 42.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -108.66 109.25 20.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.728 ' HD2' ' HB1' ' A' ' 484' ' ' ALA . 10.1 mttp -67.81 160.67 72.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.522 0.677 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.07 17.42 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 112.375 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.526 ' HB3' HD22 ' A' ' 491' ' ' LEU . 62.5 m-85 -141.39 130.91 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -151.69 117.68 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.56 142.85 17.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 8.0 pt -103.54 -27.35 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -57.84 -23.62 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' CYS . . . . . . . . . . . . . 7.7 p -141.26 -41.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 123.92 14.45 3.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.505 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.47 156.44 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 474' ' ' LYS . . . -127.47 142.07 51.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -144.79 172.6 12.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.19 -25.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -116.84 173.94 6.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -77.31 -54.6 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 8.1 t -53.5 -30.54 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 9.3 m -67.08 -31.08 71.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 476' ' ' TYR . 12.9 tp -77.87 -57.64 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -51.5 -35.96 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -53.3 -63.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -51.8 -33.21 34.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -63.66 -36.63 84.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 40.2 mtp85 -116.37 34.95 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.99 -44.51 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -119.66 -46.68 2.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -58.38 -70.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.9 p -97.92 135.6 39.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 126.85 -93.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.463 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -101.58 138.45 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt 51.85 68.25 3.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 165.09 32.14 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 4.0 t -150.35 159.97 44.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -144.64 72.34 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -35.72 12.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' SER . . . . . . . . . . . . . 1.5 m 57.95 41.19 24.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' SER . . . . . . . . . . . . . 4.7 m -124.87 95.77 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.166 -0.797 . . . . 0.0 112.486 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_